"Covidence #","Study ID","Title","Reviewer Name","Peer-reviewed or Preprint","Journal","Database/Study ID","Date of Publication (Month and Year)","Title of paper","First Author (Last name and Initials)","Retrospective/Prospective","Study Design","Does the study primarily compare cancer vs. non-cancer cohorts?","Does the study include inpatients/ outpatients/both/ or non-specific?","Study Country/Countries","Study Regions/Cities","Hospital(s)","Study Start Date","Study End Date","Total study size (number of patients)","Primary Outcomes of Study","Secondary outcomes of study","outcomes described","Explicitly included vaccinated patients","Definition of Cancer patient","Comparison group","Comparator group matching strategy","Baseline characteristics:","Cancer Age (measure of centre) e.g. mean/median","Cancer Age (centre)","Cancer Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance","Cancer Age (spread)","Cancer Sex (% male)","Cancer Total number","Control (non-cancer) Age (measure of centre) e.g. mean/median","Control (non-cancer) Age (centre)","Control (non-cancer) Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance","Control (non-cancer) Age (spread)","Control (non-cancer) Sex (% male)","Control (non-cancer) Total number","Which COVID-19 variant does the study identify?","Co-morbidities:","Smoking Number (cancer)","Smoking Percentage (cancer)","Smoking Number (control)","Smoking Percentage (control)","Smoking Measure of Association","Smoking OR/RR value","Smoking 95% Confidence Interval","Smoking p-value","Hypertension Number (cancer)","Hypertension Percentage (cancer)","Hypertension Number (control)","Hypertension Percentage (control)","Hypertension Measure of Association","Hypertension OR/RR value","Hypertension 95% Confidence Interval","Hypertension p-value","Diabetes Mellitus (DM) Number (cancer)","Diabetes Mellitus (DM) Percentage (cancer)","Diabetes Mellitus (DM) Number (control)","Diabetes Mellitus (DM) Percentage (control)","Diabetes Mellitus (DM) Measure of Association","Diabetes Mellitus (DM) OR/RR value","Diabetes Mellitus (DM) 95% Confidence Interval","Diabetes Mellitus (DM) p-value","Cardiovascular Disease (CVD) Number (cancer)","Cardiovascular Disease (CVD) Percentage (cancer)","Cardiovascular Disease (CVD) Number (control)","Cardiovascular Disease (CVD) Percentage (control)","Cardiovascular Disease (CVD) Measure of Association","Cardiovascular Disease (CVD) OR/RR value","Cardiovascular Disease (CVD) 95% Confidence Interval","Cardiovascular Disease (CVD) p-value","Cerebrovascular Disease Number (cancer)","Cerebrovascular Disease Percentage (cancer)","Cerebrovascular Disease Number (control)","Cerebrovascular Disease Percentage (control)","Cerebrovascular Disease Measure of Association","Cerebrovascular Disease OR/RR value","Cerebrovascular Disease 95% Confidence Interval","Cerebrovascular Disease p-value","Chronic Liver Disease Number (cancer)","Chronic Liver Disease Percentage (cancer)","Chronic Liver Disease Number (control)","Chronic Liver Disease Percentage (control)","Chronic Liver Disease Measure of Association","Chronic Liver Disease OR/RR value","Chronic Liver Disease 95% Confidence Interval","Chronic Liver Disease p-value","Chronic Kidney Disease Number (cancer)","Chronic Kidney Disease Percentage (cancer)","Chronic Kidney Disease Number (control)","Chronic Kidney Disease Percentage (control)","Chronic Kidney Disease Measure of Association","Chronic Kidney Disease OR/RR value","Chronic Kidney Disease 95% Confidence Interval","Chronic Kidney Disease p-value","Chronic Lung Disease Number (cancer)","Chronic Lung Disease Percentage (cancer)","Chronic Lung Disease Number (control)","Chronic Lung Disease Percentage (control)","Chronic Lung Disease Measure of Association","Chronic Lung Disease OR/RR value","Chronic Lung Disease 95% Confidence Interval","Chronic Lung Disease p-value","Immunodeficiency/ Immunosuppression Number (cancer)","Immunodeficiency/ Immunosuppression Percentage (cancer)","Immunodeficiency/ Immunosuppression Number (control)","Immunodeficiency/ Immunosuppression Percentage (control)","Immunodeficiency/ Immunosuppression Measure of Association","Immunodeficiency/ Immunosuppression OR/RR value","Immunodeficiency/ Immunosuppression 95% Confidence Interval","Immunodeficiency/ Immunosuppression p-value","Autoimmune Disease Number (cancer)","Autoimmune Disease Percentage (cancer)","Autoimmune Disease Number (control)","Autoimmune Disease Percentage (control)","Autoimmune Disease Measure of Association","Autoimmune Disease OR/RR value","Autoimmune Disease 95% Confidence Interval","Autoimmune Disease p-value","Others: Please Specify Number (cancer)","Others: Please Specify Percentage (cancer)","Others: Please Specify Number (control)","Others: Please Specify Percentage (control)","Others: Please Specify Measure of Association","Others: Please Specify OR/RR value","Others: Please Specify 95% Confidence Interval","Others: Please Specify p-value","Notes Number (cancer)","Notes Percentage (cancer)","Notes Number (control)","Notes Percentage (control)","Notes Measure of Association","Notes OR/RR value","Notes 95% Confidence Interval","Notes p-value","Definition of severity","Definition of ICU admission/Critical","Definition of mortality","Definition of severe disease","Univariate or multivariate analysis?","Multivariate analysis is adjusted by","Primary Cancer Site:","Thoracic (lung, mesothelioma) Total Number of Patients","Thoracic (lung, mesothelioma) Measure of Association [mortality]","Thoracic (lung, mesothelioma) value [mortality]","Thoracic (lung, mesothelioma) 95% CI [mortality]","Thoracic (lung, mesothelioma) p-value [mortality]","Thoracic (lung, mesothelioma) cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Measure of Association [ICU]","Thoracic (lung, mesothelioma) value [ICU]","Thoracic (lung, mesothelioma) 95% CI [ICU]","Thoracic (lung, mesothelioma) p-value [ICU]","Thoracic (lung, mesothelioma) cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Measure of Association [severe disease]","Thoracic (lung, mesothelioma) value [severe disease]","Thoracic (lung, mesothelioma) 95% CI [severe disease]","Thoracic (lung, mesothelioma) p-value [severe disease]","Thoracic (lung, mesothelioma) cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Comment","Thoracic (lung, mesothelioma) Measure of Association [hospitalisation]","Thoracic (lung, mesothelioma) value [hospitalisation]","Thoracic (lung, mesothelioma) 95% CI [hospitalisation]","Thoracic (lung, mesothelioma) p-value [hospitalisation]","Thoracic (lung, mesothelioma) cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Comment.1","Breast Total Number of Patients","Breast Measure of Association [mortality]","Breast value [mortality]","Breast 95% CI [mortality]","Breast p-value [mortality]","Breast cancer: Event/Total [mortality]","Breast Non-cancer: Event/Total [mortality]","Breast Measure of Association [ICU]","Breast value [ICU]","Breast 95% CI [ICU]","Breast p-value [ICU]","Breast cancer: Event/Total [ICU]","Breast Non-cancer: Event/Total [ICU]","Breast Measure of Association [severe disease]","Breast value [severe disease]","Breast 95% CI [severe disease]","Breast p-value [severe disease]","Breast cancer: Event/Total [severe disease]","Breast Non-cancer: Event/Total [severe disease]","Breast Comment","Breast Measure of Association [hospitalisation]","Breast value [hospitalisation]","Breast 95% CI [hospitalisation]","Breast p-value [hospitalisation]","Breast cancer: Event/Total [hospitalisation]","Breast Non-cancer: Event/Total [hospitalisation]","Breast Comment.1","Upper GI (gastric, oesophageal) Total Number of Patients","Upper GI (gastric, oesophageal) Measure of Association [mortality]","Upper GI (gastric, oesophageal) value [mortality]","Upper GI (gastric, oesophageal) 95% CI [mortality]","Upper GI (gastric, oesophageal) p-value [mortality]","Upper GI (gastric, oesophageal) cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Measure of Association [ICU]","Upper GI (gastric, oesophageal) value [ICU]","Upper GI (gastric, oesophageal) 95% CI [ICU]","Upper GI (gastric, oesophageal) p-value [ICU]","Upper GI (gastric, oesophageal) cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Measure of Association [severe disease]","Upper GI (gastric, oesophageal) value [severe disease]","Upper GI (gastric, oesophageal) 95% CI [severe disease]","Upper GI (gastric, oesophageal) p-value [severe disease]","Upper GI (gastric, oesophageal) cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Comment","Upper GI (gastric, oesophageal) Measure of Association [hospitalisation]","Upper GI (gastric, oesophageal) value [hospitalisation]","Upper GI (gastric, oesophageal) 95% CI [hospitalisation]","Upper GI (gastric, oesophageal) p-value [hospitalisation]","Upper GI (gastric, oesophageal) cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Comment.1","Lower GI (colorectal, small bowel) Total Number of Patients","Lower GI (colorectal, small bowel) Measure of Association [mortality]","Lower GI (colorectal, small bowel) value [mortality]","Lower GI (colorectal, small bowel) 95% CI [mortality]","Lower GI (colorectal, small bowel) p-value [mortality]","Lower GI (colorectal, small bowel) cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Measure of Association [ICU]","Lower GI (colorectal, small bowel) value [ICU]","Lower GI (colorectal, small bowel) 95% CI [ICU]","Lower GI (colorectal, small bowel) p-value [ICU]","Lower GI (colorectal, small bowel) cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Measure of Association [severe disease]","Lower GI (colorectal, small bowel) value [severe disease]","Lower GI (colorectal, small bowel) 95% CI [severe disease]","Lower GI (colorectal, small bowel) p-value [severe disease]","Lower GI (colorectal, small bowel) cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Comment","Lower GI (colorectal, small bowel) Measure of Association [hospitalisation]","Lower GI (colorectal, small bowel) value [hospitalisation]","Lower GI (colorectal, small bowel) 95% CI [hospitalisation]","Lower GI (colorectal, small bowel) p-value [hospitalisation]","Lower GI (colorectal, small bowel) cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Comment.1","Hepatobiliary (liver, pancreas, gall bladder) Total Number of Patients","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [mortality]","Hepatobiliary (liver, pancreas, gall bladder) value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [mortality]","Hepatobiliary (liver, pancreas, gall bladder) p-value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [ICU]","Hepatobiliary (liver, pancreas, gall bladder) value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [ICU]","Hepatobiliary (liver, pancreas, gall bladder) p-value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) p-value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Comment","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) p-value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Comment.1","Renal Total Number of Patients","Renal Measure of Association [mortality]","Renal value [mortality]","Renal 95% CI [mortality]","Renal p-value [mortality]","Renal cancer: Event/Total [mortality]","Renal Non-cancer: Event/Total [mortality]","Renal Measure of Association [ICU]","Renal value [ICU]","Renal 95% CI [ICU]","Renal p-value [ICU]","Renal cancer: Event/Total [ICU]","Renal Non-cancer: Event/Total [ICU]","Renal Measure of Association [severe disease]","Renal value [severe disease]","Renal 95% CI [severe disease]","Renal p-value [severe disease]","Renal cancer: Event/Total [severe disease]","Renal Non-cancer: Event/Total [severe disease]","Renal Comment","Renal Measure of Association [hospitalisation]","Renal value [hospitalisation]","Renal 95% CI [hospitalisation]","Renal p-value [hospitalisation]","Renal cancer: Event/Total [hospitalisation]","Renal Non-cancer: Event/Total [hospitalisation]","Renal Comment.1","Urology (ureter, bladder, prostate) Total Number of Patients","Urology (ureter, bladder, prostate) Measure of Association [mortality]","Urology (ureter, bladder, prostate) value [mortality]","Urology (ureter, bladder, prostate) 95% CI [mortality]","Urology (ureter, bladder, prostate) p-value [mortality]","Urology (ureter, bladder, prostate) cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Measure of Association [ICU]","Urology (ureter, bladder, prostate) value [ICU]","Urology (ureter, bladder, prostate) 95% CI [ICU]","Urology (ureter, bladder, prostate) p-value [ICU]","Urology (ureter, bladder, prostate) cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Measure of Association [severe disease]","Urology (ureter, bladder, prostate) value [severe disease]","Urology (ureter, bladder, prostate) 95% CI [severe disease]","Urology (ureter, bladder, prostate) p-value [severe disease]","Urology (ureter, bladder, prostate) cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Comment","Urology (ureter, bladder, prostate) Measure of Association [hospitalisation]","Urology (ureter, bladder, prostate) value [hospitalisation]","Urology (ureter, bladder, prostate) 95% CI [hospitalisation]","Urology (ureter, bladder, prostate) p-value [hospitalisation]","Urology (ureter, bladder, prostate) cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Comment.1","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Total Number of Patients","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment.1","CNS Total Number of Patients","CNS Measure of Association [mortality]","CNS value [mortality]","CNS 95% CI [mortality]","CNS p-value [mortality]","CNS cancer: Event/Total [mortality]","CNS Non-cancer: Event/Total [mortality]","CNS Measure of Association [ICU]","CNS value [ICU]","CNS 95% CI [ICU]","CNS p-value [ICU]","CNS cancer: Event/Total [ICU]","CNS Non-cancer: Event/Total [ICU]","CNS Measure of Association [severe disease]","CNS value [severe disease]","CNS 95% CI [severe disease]","CNS p-value [severe disease]","CNS cancer: Event/Total [severe disease]","CNS Non-cancer: Event/Total [severe disease]","CNS Comment","CNS Measure of Association [hospitalisation]","CNS value [hospitalisation]","CNS 95% CI [hospitalisation]","CNS p-value [hospitalisation]","CNS cancer: Event/Total [hospitalisation]","CNS Non-cancer: Event/Total [hospitalisation]","CNS Comment.1","Head and neck Total Number of Patients","Head and neck Measure of Association [mortality]","Head and neck value [mortality]","Head and neck 95% CI [mortality]","Head and neck p-value [mortality]","Head and neck cancer: Event/Total [mortality]","Head and neck Non-cancer: Event/Total [mortality]","Head and neck Measure of Association [ICU]","Head and neck value [ICU]","Head and neck 95% CI [ICU]","Head and neck p-value [ICU]","Head and neck cancer: Event/Total [ICU]","Head and neck Non-cancer: Event/Total [ICU]","Head and neck Measure of Association [severe disease]","Head and neck value [severe disease]","Head and neck 95% CI [severe disease]","Head and neck p-value [severe disease]","Head and neck cancer: Event/Total [severe disease]","Head and neck Non-cancer: Event/Total [severe disease]","Head and neck Comment","Head and neck Measure of Association [hospitalisation]","Head and neck value [hospitalisation]","Head and neck 95% CI [hospitalisation]","Head and neck p-value [hospitalisation]","Head and neck cancer: Event/Total [hospitalisation]","Head and neck Non-cancer: Event/Total [hospitalisation]","Head and neck Comment.1","Skin (including melanoma) Total Number of Patients","Skin (including melanoma) Measure of Association [mortality]","Skin (including melanoma) value [mortality]","Skin (including melanoma) 95% CI [mortality]","Skin (including melanoma) p-value [mortality]","Skin (including melanoma) cancer: Event/Total [mortality]","Skin (including melanoma) Non-cancer: Event/Total [mortality]","Skin (including melanoma) Measure of Association [ICU]","Skin (including melanoma) value [ICU]","Skin (including melanoma) 95% CI [ICU]","Skin (including melanoma) p-value [ICU]","Skin (including melanoma) cancer: Event/Total [ICU]","Skin (including melanoma) Non-cancer: Event/Total [ICU]","Skin (including melanoma) Measure of Association [severe disease]","Skin (including melanoma) value [severe disease]","Skin (including melanoma) 95% CI [severe disease]","Skin (including melanoma) p-value [severe disease]","Skin (including melanoma) cancer: Event/Total [severe disease]","Skin (including melanoma) Non-cancer: Event/Total [severe disease]","Skin (including melanoma) Comment","Skin (including melanoma) Measure of Association [hospitalisation]","Skin (including melanoma) value [hospitalisation]","Skin (including melanoma) 95% CI [hospitalisation]","Skin (including melanoma) p-value [hospitalisation]","Skin (including melanoma) cancer: Event/Total [hospitalisation]","Skin (including melanoma) Non-cancer: Event/Total [hospitalisation]","Skin (including melanoma) Comment.1","Sarcoma (including Musculo skeletal) Total Number of Patients","Sarcoma (including Musculo skeletal) Measure of Association [mortality]","Sarcoma (including Musculo skeletal) value [mortality]","Sarcoma (including Musculo skeletal) 95% CI [mortality]","Sarcoma (including Musculo skeletal) p-value [mortality]","Sarcoma (including Musculo skeletal) cancer: Event/Total [mortality]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [mortality]","Sarcoma (including Musculo skeletal) Measure of Association [ICU]","Sarcoma (including Musculo skeletal) value [ICU]","Sarcoma (including Musculo skeletal) 95% CI [ICU]","Sarcoma (including Musculo skeletal) p-value [ICU]","Sarcoma (including Musculo skeletal) cancer: Event/Total [ICU]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [ICU]","Sarcoma (including Musculo skeletal) Measure of Association [severe disease]","Sarcoma (including Musculo skeletal) value [severe disease]","Sarcoma (including Musculo skeletal) 95% CI [severe disease]","Sarcoma (including Musculo skeletal) p-value [severe disease]","Sarcoma (including Musculo skeletal) cancer: Event/Total [severe disease]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [severe disease]","Sarcoma (including Musculo skeletal) Comment","Sarcoma (including Musculo skeletal) Measure of Association [hospitalisation]","Sarcoma (including Musculo skeletal) value [hospitalisation]","Sarcoma (including Musculo skeletal) 95% CI [hospitalisation]","Sarcoma (including Musculo skeletal) p-value [hospitalisation]","Sarcoma (including Musculo skeletal) cancer: Event/Total [hospitalisation]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [hospitalisation]","Sarcoma (including Musculo skeletal) Comment.1","SOLID AGGREGATED [add all solid values] Total Number of Patients","SOLID AGGREGATED [add all solid values] Measure of Association [mortality]","SOLID AGGREGATED [add all solid values] value [mortality]","SOLID AGGREGATED [add all solid values] 95% CI [mortality]","SOLID AGGREGATED [add all solid values] p-value [mortality]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [mortality]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [mortality]","SOLID AGGREGATED [add all solid values] Measure of Association [ICU]","SOLID AGGREGATED [add all solid values] value [ICU]","SOLID AGGREGATED [add all solid values] 95% CI [ICU]","SOLID AGGREGATED [add all solid values] p-value [ICU]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [ICU]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [ICU]","SOLID AGGREGATED [add all solid values] Measure of Association [severe disease]","SOLID AGGREGATED [add all solid values] value [severe disease]","SOLID AGGREGATED [add all solid values] 95% CI [severe disease]","SOLID AGGREGATED [add all solid values] p-value [severe disease]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [severe disease]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [severe disease]","SOLID AGGREGATED [add all solid values] Comment","SOLID AGGREGATED [add all solid values] Measure of Association [hospitalisation]","SOLID AGGREGATED [add all solid values] value [hospitalisation]","SOLID AGGREGATED [add all solid values] 95% CI [hospitalisation]","SOLID AGGREGATED [add all solid values] p-value [hospitalisation]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [hospitalisation]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [hospitalisation]","SOLID AGGREGATED [add all solid values] Comment.1","Haematological Total Number of Patients","Haematological Measure of Association [mortality]","Haematological value [mortality]","Haematological 95% CI [mortality]","Haematological p-value [mortality]","Haematological cancer: Event/Total [mortality]","Haematological Non-cancer: Event/Total [mortality]","Haematological Measure of Association [ICU]","Haematological value [ICU]","Haematological 95% CI [ICU]","Haematological p-value [ICU]","Haematological cancer: Event/Total [ICU]","Haematological Non-cancer: Event/Total [ICU]","Haematological Measure of Association [severe disease]","Haematological value [severe disease]","Haematological 95% CI [severe disease]","Haematological p-value [severe disease]","Haematological cancer: Event/Total [severe disease]","Haematological Non-cancer: Event/Total [severe disease]","Haematological Comment","Haematological Measure of Association [hospitalisation]","Haematological value [hospitalisation]","Haematological 95% CI [hospitalisation]","Haematological p-value [hospitalisation]","Haematological cancer: Event/Total [hospitalisation]","Haematological Non-cancer: Event/Total [hospitalisation]","Haematological Comment.1","Other Total Number of Patients","Other Measure of Association [mortality]","Other value [mortality]","Other 95% CI [mortality]","Other p-value [mortality]","Other cancer: Event/Total [mortality]","Other Non-cancer: Event/Total [mortality]","Other Measure of Association [ICU]","Other value [ICU]","Other 95% CI [ICU]","Other p-value [ICU]","Other cancer: Event/Total [ICU]","Other Non-cancer: Event/Total [ICU]","Other Measure of Association [severe disease]","Other value [severe disease]","Other 95% CI [severe disease]","Other p-value [severe disease]","Other cancer: Event/Total [severe disease]","Other Non-cancer: Event/Total [severe disease]","Other Comment","Other Measure of Association [hospitalisation]","Other value [hospitalisation]","Other 95% CI [hospitalisation]","Other p-value [hospitalisation]","Other cancer: Event/Total [hospitalisation]","Other Non-cancer: Event/Total [hospitalisation]","Other Comment.1","Unspecified Total Number of Patients","Unspecified Measure of Association [mortality]","Unspecified value [mortality]","Unspecified 95% CI [mortality]","Unspecified p-value [mortality]","Unspecified cancer: Event/Total [mortality]","Unspecified Non-cancer: Event/Total [mortality]","Unspecified Measure of Association [ICU]","Unspecified value [ICU]","Unspecified 95% CI [ICU]","Unspecified p-value [ICU]","Unspecified cancer: Event/Total [ICU]","Unspecified Non-cancer: Event/Total [ICU]","Unspecified Measure of Association [severe disease]","Unspecified value [severe disease]","Unspecified 95% CI [severe disease]","Unspecified p-value [severe disease]","Unspecified cancer: Event/Total [severe disease]","Unspecified Non-cancer: Event/Total [severe disease]","Unspecified Comment","Unspecified Measure of Association [hospitalisation]","Unspecified value [hospitalisation]","Unspecified 95% CI [hospitalisation]","Unspecified p-value [hospitalisation]","Unspecified cancer: Event/Total [hospitalisation]","Unspecified Non-cancer: Event/Total [hospitalisation]","Unspecified Comment.1","Total (OF ALL CANCERS) Total Number of Patients","Total (OF ALL CANCERS) Measure of Association [mortality]","Total (OF ALL CANCERS) value [mortality]","Total (OF ALL CANCERS) 95% CI [mortality]","Total (OF ALL CANCERS) p-value [mortality]","Total (OF ALL CANCERS) cancer: Event/Total [mortality]","Total (OF ALL CANCERS) Non-cancer: Event/Total [mortality]","Total (OF ALL CANCERS) Measure of Association [ICU]","Total (OF ALL CANCERS) value [ICU]","Total (OF ALL CANCERS) 95% CI [ICU]","Total (OF ALL CANCERS) p-value [ICU]","Total (OF ALL CANCERS) cancer: Event/Total [ICU]","Total (OF ALL CANCERS) Non-cancer: Event/Total [ICU]","Total (OF ALL CANCERS) Measure of Association [severe disease]","Total (OF ALL CANCERS) value [severe disease]","Total (OF ALL CANCERS) 95% CI [severe disease]","Total (OF ALL CANCERS) p-value [severe disease]","Total (OF ALL CANCERS) cancer: Event/Total [severe disease]","Total (OF ALL CANCERS) Non-cancer: Event/Total [severe disease]","Total (OF ALL CANCERS) Comment","Total (OF ALL CANCERS) Measure of Association [hospitalisation]","Total (OF ALL CANCERS) value [hospitalisation]","Total (OF ALL CANCERS) 95% CI [hospitalisation]","Total (OF ALL CANCERS) p-value [hospitalisation]","Total (OF ALL CANCERS) cancer: Event/Total [hospitalisation]","Total (OF ALL CANCERS) Non-cancer: Event/Total [hospitalisation]","Total (OF ALL CANCERS) Comment.1","Metastasis status:","M0/Stage I-III: No metastasis Total number of Patients","M0/Stage I-III: No metastasis Measure of Association [mortality]","M0/Stage I-III: No metastasis value [mortality]","M0/Stage I-III: No metastasis 95% CI [mortality]","M0/Stage I-III: No metastasis p-value [mortality]","M0/Stage I-III: No metastasis cancer: Event/Total [mortality]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [mortality]","M0/Stage I-III: No metastasis Measure of Association [ICU]","M0/Stage I-III: No metastasis value [ICU]","M0/Stage I-III: No metastasis 95% CI [ICU]","M0/Stage I-III: No metastasis p-value [ICU]","M0/Stage I-III: No metastasis cancer: Event/Total [ICU]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [ICU]","M0/Stage I-III: No metastasis Measure of Association [severe]","M0/Stage I-III: No metastasis value [severe]","M0/Stage I-III: No metastasis 95% CI [severe]","M0/Stage I-III: No metastasis p-value [severe]","M0/Stage I-III: No metastasis cancer: Event/Total [severe]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [severe]","M0/Stage I-III: No metastasis Comment","M0/Stage I-III: No metastasis Measure of Association [hospitalisation]","M0/Stage I-III: No metastasis value [hospitalisation]","M0/Stage I-III: No metastasis 95% CI [hospitalisation]","M0/Stage I-III: No metastasis p-value [hospitalisation]","M0/Stage I-III: No metastasis cancer: Event/Total [hospitalisation]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [hospitalisation]","M0/Stage I-III: No metastasis Comment.1","M1/Stage IV: metastatic disease Total number of Patients","M1/Stage IV: metastatic disease Measure of Association [mortality]","M1/Stage IV: metastatic disease value [mortality]","M1/Stage IV: metastatic disease 95% CI [mortality]","M1/Stage IV: metastatic disease p-value [mortality]","M1/Stage IV: metastatic disease cancer: Event/Total [mortality]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [mortality]","M1/Stage IV: metastatic disease Measure of Association [ICU]","M1/Stage IV: metastatic disease value [ICU]","M1/Stage IV: metastatic disease 95% CI [ICU]","M1/Stage IV: metastatic disease p-value [ICU]","M1/Stage IV: metastatic disease cancer: Event/Total [ICU]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [ICU]","M1/Stage IV: metastatic disease Measure of Association [severe]","M1/Stage IV: metastatic disease value [severe]","M1/Stage IV: metastatic disease 95% CI [severe]","M1/Stage IV: metastatic disease p-value [severe]","M1/Stage IV: metastatic disease cancer: Event/Total [severe]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [severe]","M1/Stage IV: metastatic disease Comment","M1/Stage IV: metastatic disease Measure of Association [hospitalisation]","M1/Stage IV: metastatic disease value [hospitalisation]","M1/Stage IV: metastatic disease 95% CI [hospitalisation]","M1/Stage IV: metastatic disease p-value [hospitalisation]","M1/Stage IV: metastatic disease cancer: Event/Total [hospitalisation]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [hospitalisation]","M1/Stage IV: metastatic disease Comment.1","Unknown Total number of Patients","Unknown Measure of Association [mortality]","Unknown value [mortality]","Unknown 95% CI [mortality]","Unknown p-value [mortality]","Unknown cancer: Event/Total [mortality]","Unknown Non-cancer: Event/Total [mortality]","Unknown Measure of Association [ICU]","Unknown value [ICU]","Unknown 95% CI [ICU]","Unknown p-value [ICU]","Unknown cancer: Event/Total [ICU]","Unknown Non-cancer: Event/Total [ICU]","Unknown Measure of Association [severe]","Unknown value [severe]","Unknown 95% CI [severe]","Unknown p-value [severe]","Unknown cancer: Event/Total [severe]","Unknown Non-cancer: Event/Total [severe]","Unknown Comment","Unknown Measure of Association [hospitalisation]","Unknown value [hospitalisation]","Unknown 95% CI [hospitalisation]","Unknown p-value [hospitalisation]","Unknown cancer: Event/Total [hospitalisation]","Unknown Non-cancer: Event/Total [hospitalisation]","Unknown Comment.1","Treatment type:","Chemotherapy Total number of patients","Chemotherapy percentage","Chemotherapy Measure of Association [mortality]","Chemotherapy value [mortality]","Chemotherapy 95% CI [mortality]","Chemotherapy p-value [mortality]","Chemotherapy cancer: Event/Total [mortality]","Chemotherapy Non-cancer: Event/Total [mortality]","Chemotherapy Measure of Association [ICU]","Chemotherapy value [ICU]","Chemotherapy 95% CI [ICU]","Chemotherapy p-value [ICU]","Chemotherapy cancer: Event/Total [ICU]","Chemotherapy Non-cancer: Event/Total [ICU]","Chemotherapy Measure of Association [severe]","Chemotherapy value [severe]","Chemotherapy 95% CI [severe]","Chemotherapy p-value [severe]","Chemotherapy cancer: Event/Total [severe]","Chemotherapy Non-cancer: Event/Total [severe]","Chemotherapy Comment [incl. name of targeted/immunotherapy]","Chemotherapy Measure of Association [hospitalisation]","Chemotherapy value [hospitalisation]","Chemotherapy 95% CI [hospitalisation]","Chemotherapy p-value [hospitalisation]","Chemotherapy cancer: Event/Total [hospitalisation]","Chemotherapy Non-cancer: Event/Total [hospitalisation]","Chemotherapy Comment","Hormonal therapy Total number of patients","Hormonal therapy percentage","Hormonal therapy Measure of Association [mortality]","Hormonal therapy value [mortality]","Hormonal therapy 95% CI [mortality]","Hormonal therapy p-value [mortality]","Hormonal therapy cancer: Event/Total [mortality]","Hormonal therapy Non-cancer: Event/Total [mortality]","Hormonal therapy Measure of Association [ICU]","Hormonal therapy value [ICU]","Hormonal therapy 95% CI [ICU]","Hormonal therapy p-value [ICU]","Hormonal therapy cancer: Event/Total [ICU]","Hormonal therapy Non-cancer: Event/Total [ICU]","Hormonal therapy Measure of Association [severe]","Hormonal therapy value [severe]","Hormonal therapy 95% CI [severe]","Hormonal therapy p-value [severe]","Hormonal therapy cancer: Event/Total [severe]","Hormonal therapy Non-cancer: Event/Total [severe]","Hormonal therapy Comment [incl. name of targeted/immunotherapy]","Hormonal therapy Measure of Association [hospitalisation]","Hormonal therapy value [hospitalisation]","Hormonal therapy 95% CI [hospitalisation]","Hormonal therapy p-value [hospitalisation]","Hormonal therapy cancer: Event/Total [hospitalisation]","Hormonal therapy Non-cancer: Event/Total [hospitalisation]","Hormonal therapy Comment","Targeted therapy (RTK inhibitor/mAb against receptors) Total number of patients","Targeted therapy (RTK inhibitor/mAb against receptors) percentage","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) value [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) value [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) value [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) Comment [incl. name of targeted/immunotherapy]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) value [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) Comment","radiotherapy Total number of patients","radiotherapy percentage","radiotherapy Measure of Association [mortality]","radiotherapy value [mortality]","radiotherapy 95% CI [mortality]","radiotherapy p-value [mortality]","radiotherapy cancer: Event/Total [mortality]","radiotherapy Non-cancer: Event/Total [mortality]","radiotherapy Measure of Association [ICU]","radiotherapy value [ICU]","radiotherapy 95% CI [ICU]","radiotherapy p-value [ICU]","radiotherapy cancer: Event/Total [ICU]","radiotherapy Non-cancer: Event/Total [ICU]","radiotherapy Measure of Association [severe]","radiotherapy value [severe]","radiotherapy 95% CI [severe]","radiotherapy p-value [severe]","radiotherapy cancer: Event/Total [severe]","radiotherapy Non-cancer: Event/Total [severe]","radiotherapy Comment [incl. name of targeted/immunotherapy]","radiotherapy Measure of Association [hospitalisation]","radiotherapy value [hospitalisation]","radiotherapy 95% CI [hospitalisation]","radiotherapy p-value [hospitalisation]","radiotherapy cancer: Event/Total [hospitalisation]","radiotherapy Non-cancer: Event/Total [hospitalisation]","radiotherapy Comment","immunotherapy (immune checkpoint inhibitors/CAR-T) Total number of patients","immunotherapy (immune checkpoint inhibitors/CAR-T) percentage","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) Comment [incl. name of targeted/immunotherapy]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) Comment","surgery Total number of patients","surgery percentage","surgery Measure of Association [mortality]","surgery value [mortality]","surgery 95% CI [mortality]","surgery p-value [mortality]","surgery cancer: Event/Total [mortality]","surgery Non-cancer: Event/Total [mortality]","surgery Measure of Association [ICU]","surgery value [ICU]","surgery 95% CI [ICU]","surgery p-value [ICU]","surgery cancer: Event/Total [ICU]","surgery Non-cancer: Event/Total [ICU]","surgery Measure of Association [severe]","surgery value [severe]","surgery 95% CI [severe]","surgery p-value [severe]","surgery cancer: Event/Total [severe]","surgery Non-cancer: Event/Total [severe]","surgery Comment [incl. name of targeted/immunotherapy]","surgery Measure of Association [hospitalisation]","surgery value [hospitalisation]","surgery 95% CI [hospitalisation]","surgery p-value [hospitalisation]","surgery cancer: Event/Total [hospitalisation]","surgery Non-cancer: Event/Total [hospitalisation]","surgery Comment","COVID variants:","WT/Wu-1 Total Number of patients","WT/Wu-1 Percentage","WT/Wu-1 Measure of Association [mortality]","WT/Wu-1 value [mortality]","WT/Wu-1 95% CI [mortality]","WT/Wu-1 p-value [mortality]","WT/Wu-1 cancer: Event/Total [mortality]","WT/Wu-1 Non-cancer: Event/Total [mortality]","WT/Wu-1 Measure of Association [ICU]","WT/Wu-1 value [ICU]","WT/Wu-1 95% CI [ICU]","WT/Wu-1 p-value [ICU]","WT/Wu-1 cancer: Event/Total [ICU]","WT/Wu-1 Non-cancer: Event/Total [ICU]","WT/Wu-1 Measure of Association [severe]","WT/Wu-1 value [severe]","WT/Wu-1 95% CI [severe]","WT/Wu-1 p-value [severe]","WT/Wu-1 cancer: Event/Total [severe]","WT/Wu-1 Non-cancer: Event/Total [severe]","WT/Wu-1 Comment","WT/Wu-1 Measure of Association [hospitalisation]","WT/Wu-1 value [hospitalisation]","WT/Wu-1 95% CI [hospitalisation]","WT/Wu-1 p-value [hospitalisation]","WT/Wu-1 cancer: Event/Total [hospitalisation]","WT/Wu-1 Non-cancer: Event/Total [hospitalisation]","WT/Wu-1 Comment.1","Beta Total Number of patients","Beta Percentage","Beta Measure of Association [mortality]","Beta value [mortality]","Beta 95% CI [mortality]","Beta p-value [mortality]","Beta cancer: Event/Total [mortality]","Beta Non-cancer: Event/Total [mortality]","Beta Measure of Association [ICU]","Beta value [ICU]","Beta 95% CI [ICU]","Beta p-value [ICU]","Beta cancer: Event/Total [ICU]","Beta Non-cancer: Event/Total [ICU]","Beta Measure of Association [severe]","Beta value [severe]","Beta 95% CI [severe]","Beta p-value [severe]","Beta cancer: Event/Total [severe]","Beta Non-cancer: Event/Total [severe]","Beta Comment","Beta Measure of Association [hospitalisation]","Beta value [hospitalisation]","Beta 95% CI [hospitalisation]","Beta p-value [hospitalisation]","Beta cancer: Event/Total [hospitalisation]","Beta Non-cancer: Event/Total [hospitalisation]","Beta Comment.1","Gamma Total Number of patients","Gamma Percentage","Gamma Measure of Association [mortality]","Gamma value [mortality]","Gamma 95% CI [mortality]","Gamma p-value [mortality]","Gamma cancer: Event/Total [mortality]","Gamma Non-cancer: Event/Total [mortality]","Gamma Measure of Association [ICU]","Gamma value [ICU]","Gamma 95% CI [ICU]","Gamma p-value [ICU]","Gamma cancer: Event/Total [ICU]","Gamma Non-cancer: Event/Total [ICU]","Gamma Measure of Association [severe]","Gamma value [severe]","Gamma 95% CI [severe]","Gamma p-value [severe]","Gamma cancer: Event/Total [severe]","Gamma Non-cancer: Event/Total [severe]","Gamma Comment","Gamma Measure of Association [hospitalisation]","Gamma value [hospitalisation]","Gamma 95% CI [hospitalisation]","Gamma p-value [hospitalisation]","Gamma cancer: Event/Total [hospitalisation]","Gamma Non-cancer: Event/Total [hospitalisation]","Gamma Comment.1","Delta Total Number of patients","Delta Percentage","Delta Measure of Association [mortality]","Delta value [mortality]","Delta 95% CI [mortality]","Delta p-value [mortality]","Delta cancer: Event/Total [mortality]","Delta Non-cancer: Event/Total [mortality]","Delta Measure of Association [ICU]","Delta value [ICU]","Delta 95% CI [ICU]","Delta p-value [ICU]","Delta cancer: Event/Total [ICU]","Delta Non-cancer: Event/Total [ICU]","Delta Measure of Association [severe]","Delta value [severe]","Delta 95% CI [severe]","Delta p-value [severe]","Delta cancer: Event/Total [severe]","Delta Non-cancer: Event/Total [severe]","Delta Comment","Delta Measure of Association [hospitalisation]","Delta value [hospitalisation]","Delta 95% CI [hospitalisation]","Delta p-value [hospitalisation]","Delta cancer: Event/Total [hospitalisation]","Delta Non-cancer: Event/Total [hospitalisation]","Delta Comment.1","Omicron Total Number of patients","Omicron Percentage","Omicron Measure of Association [mortality]","Omicron value [mortality]","Omicron 95% CI [mortality]","Omicron p-value [mortality]","Omicron cancer: Event/Total [mortality]","Omicron Non-cancer: Event/Total [mortality]","Omicron Measure of Association [ICU]","Omicron value [ICU]","Omicron 95% CI [ICU]","Omicron p-value [ICU]","Omicron cancer: Event/Total [ICU]","Omicron Non-cancer: Event/Total [ICU]","Omicron Measure of Association [severe]","Omicron value [severe]","Omicron 95% CI [severe]","Omicron p-value [severe]","Omicron cancer: Event/Total [severe]","Omicron Non-cancer: Event/Total [severe]","Omicron Comment","Omicron Measure of Association [hospitalisation]","Omicron value [hospitalisation]","Omicron 95% CI [hospitalisation]","Omicron p-value [hospitalisation]","Omicron cancer: Event/Total [hospitalisation]","Omicron Non-cancer: Event/Total [hospitalisation]","Omicron Comment.1","Unspecified/Total Total Number of patients","Unspecified/Total Percentage","Unspecified/Total Measure of Association [mortality]","Unspecified/Total value [mortality]","Unspecified/Total 95% CI [mortality]","Unspecified/Total p-value [mortality]","Unspecified/Total cancer: Event/Total [mortality]","Unspecified/Total Non-cancer: Event/Total [mortality]","Unspecified/Total Measure of Association [ICU]","Unspecified/Total value [ICU]","Unspecified/Total 95% CI [ICU]","Unspecified/Total p-value [ICU]","Unspecified/Total cancer: Event/Total [ICU]","Unspecified/Total Non-cancer: Event/Total [ICU]","Unspecified/Total Measure of Association [severe]","Unspecified/Total value [severe]","Unspecified/Total 95% CI [severe]","Unspecified/Total p-value [severe]","Unspecified/Total cancer: Event/Total [severe]","Unspecified/Total Non-cancer: Event/Total [severe]","Unspecified/Total Comment","Unspecified/Total Measure of Association [hospitalisation]","Unspecified/Total value [hospitalisation]","Unspecified/Total 95% CI [hospitalisation]","Unspecified/Total p-value [hospitalisation]","Unspecified/Total cancer: Event/Total [hospitalisation]","Unspecified/Total Non-cancer: Event/Total [hospitalisation]","Unspecified/Total Comment.1","Other Total Number of patients","Other Percentage","Other Measure of Association [mortality].1","Other value [mortality].1","Other 95% CI [mortality].1","Other p-value [mortality].1","Other cancer: Event/Total [mortality].1","Other Non-cancer: Event/Total [mortality].1","Other Measure of Association [ICU].1","Other value [ICU].1","Other 95% CI [ICU].1","Other p-value [ICU].1","Other cancer: Event/Total [ICU].1","Other Non-cancer: Event/Total [ICU].1","Other Measure of Association [severe]","Other value [severe]","Other 95% CI [severe]","Other p-value [severe]","Other cancer: Event/Total [severe]","Other Non-cancer: Event/Total [severe]","Other Comment.2","Other Measure of Association [hospitalisation].1","Other value [hospitalisation].1","Other 95% CI [hospitalisation].1","Other p-value [hospitalisation].1","Other cancer: Event/Total [hospitalisation].1","Other Non-cancer: Event/Total [hospitalisation].1","Other Comment.3","COVID vaccination status:","vaccinated Total number of patients","vaccinated Percentage","vaccinated Measure of Association [mortality]","vaccinated value [mortality]","vaccinated 95% CI [mortality]","vaccinated p-value [mortality]","vaccinated cancer: Event/Total [mortality]","vaccinated Non-cancer: Event/Total [mortality]","vaccinated Measure of Association [ICU]","vaccinated value [ICU]","vaccinated 95% CI [ICU]","vaccinated p-value [ICU]","vaccinated cancer: Event/Total [ICU]","vaccinated Non-cancer: Event/Total [ICU]","vaccinated Measure of Association [severe]","vaccinated value [severe]","vaccinated 95% CI [severe]","vaccinated p-value [severe]","vaccinated cancer: Event/Total [severe]","vaccinated Non-cancer: Event/Total [severe]","vaccinated Measure of Association [hospitalisation]","vaccinated value [hospitalisation]","vaccinated 95% CI [hospitalisation]","vaccinated p-value [hospitalisation]","vaccinated cancer: Event/Total [hospitalisation]","vaccinated Non-cancer: Event/Total [hospitalisation]","vaccinated Comment","unvaccinated Total number of patients","unvaccinated Percentage","unvaccinated Measure of Association [mortality]","unvaccinated value [mortality]","unvaccinated 95% CI [mortality]","unvaccinated p-value [mortality]","unvaccinated cancer: Event/Total [mortality]","unvaccinated Non-cancer: Event/Total [mortality]","unvaccinated Measure of Association [ICU]","unvaccinated value [ICU]","unvaccinated 95% CI [ICU]","unvaccinated p-value [ICU]","unvaccinated cancer: Event/Total [ICU]","unvaccinated Non-cancer: Event/Total [ICU]","unvaccinated Measure of Association [severe]","unvaccinated value [severe]","unvaccinated 95% CI [severe]","unvaccinated p-value [severe]","unvaccinated cancer: Event/Total [severe]","unvaccinated Non-cancer: Event/Total [severe]","unvaccinated Measure of Association [hospitalisation]","unvaccinated value [hospitalisation]","unvaccinated 95% CI [hospitalisation]","unvaccinated p-value [hospitalisation]","unvaccinated cancer: Event/Total [hospitalisation]","unvaccinated Non-cancer: Event/Total [hospitalisation]","unvaccinated Comment","Is individual patient data available?"
"141173","Alsakarneh 2024","Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis.","Consensus","Peer-reviewed","J. Clin. Med","TriNetX research network","2024-04","Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis","Alsakarneh S","Retrospective","Cohort","Yes","Other: non-specific","United States","N/A","Not specified","Not mentioned","2024-02-01","30832","SARS-CoV-2 infection","emergency room (ER) visits, hospitalization, or death, all-cause critical care admission, and all-cause intubation.","Severity; Hospitalisation; ICU admission; Mortality","yes","Aged 18 years and older; (b) had an  International Classification of Disease, Ninth Revision and Tenth Revision, Clinical  Modification (ICD-10-CM) code in their EHR for CRC; (c) had documented evidence of vaccination in their EHRs.","Same source/cohort","Propensity score matching 1:1 for the following variables: (a) demographic informa- tion (age, sex, race, and ethnicity) [22–24]; (b) social determinants of adverse health outcomes (SDHOs); (c) behavioral factors (tobacco smoking, alcohol abuse); (d) vaccine types; (e) cancer treatment types; and (f) comorbidities that are related to SARS-CoV-2 morbidity and mortality ",NA,"Mean","69.6","SD","12.5","51.4%","15416","Mean","70.2","SD","12.2","50.1%","15416","Not mentioned",NA,"737","4.8%","736","4.8%","",NA,"","","9961","64.6%","10563","68.5%","",NA,"","","4261","27.6%","4577","29.7%","",NA,"","","1959 (Heart failure), 4137 (IHD)","12.7% (HF), 26.8% (IHD)","2012 (FH), 4147 (IHD)","13.1% (HF), 26.9% (IHD)","",NA,"","","1880","12.2%","2009","13.0%","",NA,"",NA,"3446","22.4%","3348","21.7%","",NA,"","","2888","18.7%","2982","19.3%","",NA,"","","3839","24.9%","3969","25.7%","","","","","189 (HIV)","1.2% (HIV)","180 (HIV)","1.2% (HIV)","","","","",NA,NA,NA,NA,"",NA,"",NA,"4300 (Obesity), 7355 (Hyperlipidemia), 388 (Dementia), 2982 (Depression), 4037 (Anxiety), 2633 (substance use), 465 (Alcohol abuse)","27.9% (Obesity), 47.7% (Hyperlipidemia), 2.5% (Dementia), 19.3% (Depression), 26.2% (Anxiety), 17.1% (Substance use), 3.0% (Alcohol abuse)","4469 (Obesity), 7815 (Hyperlipidemia), 381 (Dementia), 3155 (Depression), 4294 (Anxiety), 2769 (Substance use), 463 (Alcohol abuse)","29.0% (Obesity), 50.7% (Hyperlipidemia), 2.5% (Dementia), 20.5% (Depression), 27.9% (Anxiety), 18.0% (Substance use), 3.0% (Alcohol abuse)","","","","","","","","",NA,"","","","","","","","multivariate","Age; Sex",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"15416","aOR","1.00","0.411-2.435","1","","","aOR","1.00","0.411-2.435","1.00","","","aOR","1.00","0.411-2.435","1.00","","","Intubation","aOR","3.01","2.101-2.435","<0.0001","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"4958","32.2%","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","1011","6.6%","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"1837","11.9%","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","1418","9.2%","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","10","0.1%","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","N/A","N/A","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","aOR","1.477","0.675-3.232","0.3261","","","aOR","0.77","0.408-1.455","0.4204","","","aOR","1.15","0.552-2.395","0.7088",NA,NA,"aOR","0.884","0.64-1.223","0.4573",NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"141132","Sullivan 2023","Breast Cancer (BC) and Severe COVID-19 (C-19) Outcomes: A Matched Analysis.","Consensus","Peer-reviewed","Breast Cancer Research and Treatment","Optum de-identified C-19 Electronic Health Record dataset (2007-2022)","2024-04","Breast cancer (BC) and severe COVID‑19 (C‑19) outcomes: a matched analysis","Sullivan M","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","United States","N/A","","2020-01-01","2021-12-20","26400","Mortality","Mechanical ventilation, ICU stay, hospitalization within 30 days ","Severity; Hospitalisation; ICU admission; Mortality","yes","For  patients with BC, we used the International Classification of  Diseases 9th and 10th Revision (ICD-9 and ICD-10) diagnosis codes to identify those who had 2 or more BC diagnosis codes that were at least 30 days apart within 1 year before C-19 diagnosis date (n=5571)","Same cohort","We matched (1:1:10) patients with BC and controls with- out cancer based on age, comorbidity score, and date of C-19 diagnosis: Group 1 included patients with BC and recent cancer treatment (referred to as BC recently treated); Group 2 included patients with BC and no recent treatment (BC not recently treated); Group 3 included patients without cancer (non-cancer controls)",NA,"Median","65","IQR","55-74","0","2200","Median","65","IQR","55-74","0","22000","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","ICU stay was defined as hospitalization in an ICU without mechanical ventilation","30-day mortality. Death data were obtained from the Social Security Administration Death Master File, including month and year of death; therefore, date of death was set as the 15th of the month.","Mechanical ventilation using HCPCS codes or ICD-10 procedure codes","multivariate","Age; Comorbidities; Other: race and ethnicity, Severe obesity, Charles-Deyo Comorbidity Index score, recent skilled scaled nursing facility stay, insurance type and region",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","2200","mOR","0.8","0.57-1.13","0.21","","","mOR","1.07","0.84-1.37","0.57","","","mOR","0.88","0.63-1.22","0.43","","","Severe disease: Mechanical ventilation","mOR","0.98","0.88-1.10","0.74","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"2200","mOR","0.8","0.57-1.13","0.21","","","mOR","1.07","0.84-1.37","0.57","","","mOR","0.88","0.63-1.22","0.43","","","Severe disease: Mechanical ventilation","mOR","0.98","0.88-1.10","0.74","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"140255","Park 2024","COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors.","Consensus","Peer-reviewed","J Korean Med Sci","Korean Disease Control and Prevention Agency-COVID19-National  Health Insurance Service (K-COV-N) cohort","2023-11","COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors","Park JM","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","South Korea","N/A",NA,"2020-01-01","2022-03-31","3858035","Mortality","Severity","Severity; Hospitalisation; Mortality","yes","Time since cancer diagnosis was defined as the period from the date of cancer diagnosis to the date of COVID-19 diagnosis. *active cancer* up to 1 year. Cancer survivor was defined as a patient who had survived ≥ 5 years since the diagnosis of cancer","Same cohort","After 1:1 propensity score matching, 397,050 patients with cancer and 397,050 patients without cancer were enrolled in the main analysis. We used the nearest available matching (1:1) method to estimate the propensity score using a caliper of 0.25. Balance was assessed by a standardized mean difference of < 0.1  after matching.",NA,"","","","","42.2","397,050","","","","","44.6","397,050","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Severity as ambulatory state, hospitalization with mild state, or hospitalization with severe state using the COVID-19 severity scale by the World Health Organization. Hospitalization with mild state included no oxygen therapy or oxygen delivered using mask or nasal prongs. ","N/A","Not stated.","Hospitalization with severe state included noninvasive ventilation, high-flow oxygen, intubation and mechanical ventilation, as well as ventilation combined with additional organ support such as dialysis and extracorporeal membrane oxygenation.","multivariate","Age; Sex; Comorbidities; Other: vaccination against COVID-19, household income, and Charlson Comorbidity Index",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","mOR","1.85","1.76-1.95","","? [Not stated]/385680","","","","","","","","mOR","1.11","1.06-1.18",NA,"? [Not stated]/385680","","","mOR","1.08","1.07-1.10","","? [Not stated]/385680","","","","mOR","3.85","3.35-4.42","","? [Not stated]/11723","","","","","","","","mOR","3.18","2.78-3.64","","? [Not stated]/11723","","","mOR","1.72","1.36-1.81","","? [Not stated]/11723","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","mOR","4.95","4.60-5.34","","4015/397050","2110/397050","","","","","","","mOR","2.29","2.09-2.50","","1543/397050","1562/397050","OR for cancer diagnosis < 1 year","mOR","1.82","1.77-1.87","","44074/397050","40428/397050","OR for cancer diagnosis < 1 year",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","yes"
"138896","Li 2024","Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study.","Consensus","Peer-reviewed","BMC Pulmonary Medicine","multicenter retrospective observational cohort across 28 provinces in Chinese  mainland, involving 59 ICU","2024-10","Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study","Li C","Retrospective","Cohort","Yes","inpatient","China","N/A","","2022-11-01","2023-02-11","2030","ICU mortality","Secondary infection","Mortality","no","Cancer patients were defined as individuals with active  malignancy or those diagnosed with malignancy within  one year of developing community-acquired pneumonia  (CAP), excluding localized skin cancers and early-stage cancer.","Same multicenter cohort","To compare outcomes, we performed a three-to-one pro pensity score (PS) matching analysis estimated by logistic regression to account for potential confounding factors.  Variables involved in the PS estimation included age and APACHE II score. Matching was based on the logit of the PS using nearest-neighbor matching (greedy-type matching) with a caliper width of 0.25. ",NA,"Median","69","IQR","59-77","74.0%","77","Median","76","IQR","68-84","72.5%","1788","Omicron (B.1.1.529/BA.1)",NA,"19","24.7%","473","26.5%","",NA,"","0.793","31","40.3%","1000","55.9%","",NA,"","0.010","17","22.1%","535","29.9%","",NA,"","0.161","","","","","",NA,"","","","","","","",NA,"",NA,"2","2.6%","17","1.0%","",NA,"","0.183","5","6.5%","113","6.3%","",NA,"","0.814","10","13.0%","221","12.4%","","","","0.860","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"17","22.1%","501","28.0%","","","","0.299","Chronic heart disease","","Chronic heart disease","",NA,"","","","Severe COVID-19 was defined by any of the following criteria: (1) shortness of breath with a respiratory rate exceeding 30 breaths per minute; (2) pulse oxygen saturation of 93% or lower at rest; or (3) a partial pressure of oxygen to fraction of inspired oxygen ratio (PaO/FiO) of 300 mmHg or lower. ","Critical COVID-19 was characterized by any of the following: (1) respiratory failure requiring invasive ventilation; (2) shock; or (3) organ failure that necessitated ICU  care ","ICU mortality was defined as the death of patients within the ICU, including those expected to die following the discontinuation of treatment. ","Severe COVID-19 was defined by any of the following criteria: (1) shortness of breath with a respiratory rate exceeding 30 breaths per minute; (2) pulse oxygen saturation of 93% or lower at rest; or (3) a partial pressure of oxygen to fraction of inspired oxygen ratio (PaO/FiO) of 300 mmHg or lower. ","multivariate","Age; Other: APACHE II score",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"77","mOR","2.02","1.18-3.46","0.010","59/77","1106/1788","mOR","1.43","0.90-2.30","0.133","31/77","630/1788","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"81620","Johannesen 2021","COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway.","Consensus","Peer-reviewed","Frontiers in Oncology"," Norwegian Surveillance System for Communicable Diseases  Data on cancer and treatment was available from the Cancer Registry of Norway, the Norwegian Patient Registry and the Norwegian Prescription Database","2021-03","COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway","Johannesen T.B","Retrospective","Cohort study","Yes","inpatient and outpatient (no breakdown)","Norway","N/A","N/A","2020-01-01","2020-05-31","8410","Death due to Covid-19 ","Combined outcome: Death and/or admitted to hospital due to COVID-19","Hospitalisation; Mortality; Other: Composite outcome: Death and/or admitted to hospital due to COVID-19","no","Any cancer diagnosis before the confirmed diagnosis of Covid-19. Cancer group split by treatment recency <1 year, 1-5 years, >5 years since cancer diagnosis. Only data on <1 year since cancer diagnosis included below. ","Same cohort without history of cancer","No matching",NA,"","","","","","53","","","","","","7841","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Death and/or admission to hospital due to Covid19","","Norwegian Cause of Death Registry all deaths up to May 31, 2020 were included. The registry follows the WHO guidelines for certifying COVID-19 as a cause of death and the ICD-10 code U07.1 was used for defining COVID-19 as the underlying cause of death. The definition of the causal sequence leading to death due to COVID-19 was followed and 19 patients with COVID-19 as contributing but not underlying cause of death were excluded","Death and/or admission to hospital due to Covid19","univariate; multivariate","Age; Sex; Other: Multivariate model adjusted for age and gender.  Unclear about any other additional variables - potentially all variables in table 5  (all cancer, solid tumour, non solid tumour, localised/ regional disease, distant disease, unknown stage, chemo therapy, immunotherapy, steroids, radiotherapy, surgery).",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"53","","","","","","","","","","","","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53); 0.400 (21/53)","0.110 (854/7841); 0.110 (854/7841)","table5: Rates of death due to COVID-19 and/or admission to hospital due to COVID-19","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53;53","","","","","","","","","","","","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.396 (21/53);0.396 (21/53)","0.110 (854/7841);0.110 (854/7841)","Non cancer mortality and /or hospitalisation due covid not given but stated as comparison group ","",NA,"","","","","",NA,"71","0.130 (71/547)","","","","","","","","","","","","","uOR; mOR","5.33; 1.80","3.29-8.62; 1.07-3.01",NA,"0.394 (28/71); 0.394 (28/71)","","Chemotherapy including targeted therapy and immunotherapy last 3 months","","","","","","","","45","0.0823 (45/547)","","","","","","","","","","",NA,NA,"uOR; mOR","5.89; 1.70","3.30-10.85; 0.91-3.20",NA,"0.422 (19/45); 0.422 (19/45)",NA,NA,"","","","",NA,NA,NA,NA,NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,"","","","","","","","","7","0.0128 (7/547)","","","","","","","","","","","","","uOR; mOR","6.14; 2.67","1.37-27.46; 0.54-13.14",NA,"0.423 (3/7); 0.423 (3/7)","","","","","","","","","","15","0.0274 (15/547)","","","","","","","","","","","","","uOR; mOR","5.45; 1.63","1.94-15.36; 0.55-4.81",NA,"0.400 (6/15); 0.400 (6/15)",NA,NA,"","","","","","","","90","0.165 (90/547)","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"uOR; mOR","7.16; 2.19","4.70-10.90; 1.40-3.44",NA,"0.467 (42/90); 0.467 (42/90)",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","53","","",NA,"","","","",NA,NA,NA,NA,"","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53)","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"78588","Dai 2020","Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China","Consensus","Peer-reviewed","Cancer Control","","2020-09","Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China","Dai MY","Retrospective","Cohort","Yes","inpatient","China","Wuhan","6 hospitals in Wuhan, China: Zhongnan  Hospital  of  Wuhan  University,  The  Leishenshan  Hospital,  Hubei  Cancer  Hospital,  Union Hospital affiliated to Tongji Medical College, The Central Hospital of Wuhan, Wuhan Seventh hospital","2020-01-01","2020-03-01","217","Severe event, ICU, IMV, Death","Restricted mean survival time for each of the primary outcomes","Severity; ICU admission; Mortality","no","All cancer types, active treatment within last three months","A matched cohort of inpatients from the same six hospitals whom did not have a pre-existing diagnostic code for cancer","Matched; 1:6 for age, sex, region and time period",NA,"Mean","67.26","SD","8.40","80.6","31","","","","","","186","Not mentioned",NA,"15","48.39","","","",NA,"","","9","29.03","","","",NA,"","","4","12.90","","","",NA,"","","4","12.90","","","",NA,"","","2","6.45","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","3","9.68","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","5th edition of 2019 novel coronavirus disease diagnostic criteria published by the national health commission in China using clinical criteria and/or radiological criteria","Physical ICU admission (not just IMV)","Death before end date of the study","Clinical criteria: shortness of breath (RR>30 breaths/min), oxygen saturation <93% at rest, PaO2/FiO2 <30mmHg. Radiological criteria: progression of lung field lesions past 50% within 24-48h ","multivariate","Age; Sex; Other: Smoking hx, smoking, surgey,   Radiotherapy, Chemotherapy, Targeted therapy, Immunotherapy), IL-6 (not cancer vs no controls)",NA,"31","mHR","3.87","1.02 - 14.71","0.047","0.258 (8/31)","","mHR","4.72","1.19 - 18.72","0.027","0.322 (10/31)","","mHR","4.28","1.44 - 12.71","0.009","0.548 (17/31)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"31","mHR","3.87","1.02 - 14.71","0.047","0.258 (8/31)","","mHR","4.72","1.19 - 18.72","0.027","0.322 (10/31)","","mHR","4.28","1.44 - 12.71","0.009","0.548 (17/31)","","","","","","","","","",NA,"15","","","","","0.267 (4/15)","","","","","","0.267 (4/15)",NA,NA,NA,NA,NA,"0.467 (7/15)",NA,"","","","","","",NA,NA,"12","","","","","0.250 (3/12)","","","","","","0.333 (4/12)","","",NA,"",NA,"0.583 (7/12)","","","","","","","","","","4","","","","","0.250 (1/12)","","","","","","0.500 (2/4)","","","","","","0.500 (2/4)","","","",NA,"","","","","",NA,"10","32.3","aOR (MV reg)","0.190","0.014 - 2.537","0.209","","","","","","","","","aOR (MV reg)","0.295","0.033 - 2.635","0.275","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"3","9.68","aOR (MV reg)",NA,NA,NA,"","","","","","","","","aOR (MV reg)",NA,NA,NA,"",NA,"","","","","","","","","8","25.8","aOR (MV reg)","5.150","0.332 - 79.969","0.241","","","","","","","","","aOR (MV reg)","1.555","0.137 - 17.705","0.722","","","","","","","","","","","4","12.9","aOR (MV reg)","0.983","0.047 - 20.494","0.991","","","","","","","","","aOR (MV reg)","0.368","0.025 - 5.415","0.466","",NA,NA,"","","","","","","","7","22.6","aOR (MV reg)","1.255","1.019 - 4.287","0.03","","",NA,NA,NA,NA,NA,NA,"aOR (MV reg)","1.342","0.049 - 2.366","0.027","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"31","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","yes"
"75567","Bazgir 2022","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Consensus","Peer-reviewed","International Journal of Cancer Management","all patients with COVID-19 who were admitted to the hospital were eligible for enrolment into the Ilam COVID-19 monitoring and evaluation project (Ilam-CEMP). The Ilam-CEMP is one of the first registries in the country (Iran) that enables near real-time monitoring of essential data and trends about the effect of COVID-19 on patients","2022-10","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Bazgir N","Retrospective","Cohort","Yes","inpatient","Iran","Ilam","urban primary and secondary academic hospital in Ilam.","2020-03-05","2021-03-21","320","This study’s primary outcome was in-hospital mortality or discharge from the hospital.","","ICU admission; Mortality","no","All types cancer; active cancer = receiving treatments for cancer such as adjuvant, radical, cura-tve, neo-adjuvant settings, or chemotherapy within the past two months. ","At the same time, 256 controls matched cases by age, gender, and without a history of cancer were randomly selected from the same registry dataset.","Matched; 64:256; age, gender, co-morbidities.",NA,"Mean","63.9","SD","2.5","53.1","64","Mean","62.1","SD","0.8","52.7","256","Not mentioned",NA,"0","0","7","2.7","",NA,"","","21","32.8","97","37.9","",NA,"","0.45","11","17.2","64","25","",NA,"","0.19","14","21.9","76","29.7","",NA,"","0.21","8","3.1","2","3.1","",NA,"","1","","","","","",NA,"","","14","5.5","5","7.8","",NA,"","0.48","20","7.8","5","7.8","","","","1.00","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","No definition stated.","","univariate; multivariate","Age; Sex",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"64","uHR; mHR","2.79; 2.27","1.70-4.59; 1.25-4.13","<0.001; 0.007","0.453 (29/64); 0.453 (29/64)","0.137 (35/256); 0.137 (35/256)","uHR; mHR","10.8; 6.68","5.11-22.72; 2.97-15.01","<0.001; <0.001","0.563 (36/64); 0.563 (36/64)","0.266 (68/256); 0.266 (68/256)","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"28","44","uHR; mHR","3.14; 1.65","1.77-5.57; 0.60-4.56","<0.001; 0.33","0.571 (16/27); 0.571 (16/27)","0.137 (35/256); 0.137 (35/256)","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"75065","Zhou 2023","Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study","Consensus","Peer-reviewed","Cancer Medicine","population based study on patients who presented to Hong Kong public hospitals and outpatient clinics using CDARS, a territory-wide database that centralizes patient information from 43 local hospitals and their associated ambulatory and outpatient facilities","2022-01","Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study","Zhou J","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","China","Hong Kong","43 local hospitals and their associated ambulatory and outpatient facilities","2020-01-01","2020-12-08","6089","composite endpoint of requirement for intubation, ICU admission and 30-day mortality. Details regarding the individual components that constitute this composite endpoint were extracted from CDARS","","Severity; ICU admission; Mortality; Other: The primary outcome was a severe composite endpoint of requirement for intubation, ICU admission and 30-day mortality.","no","The inclusion criteria for this study were as follows: patients who had a positive RT-PCR for COVID-19, had pre-existing active malignancy diagnosed by clinical, radiological and pathological investigations and were admitted to the public hospital within the stated time period. The exclusion criteria included malignancy diagnosed after COVID-19 infection and patients in complete remission from cancer.","Same hospitals   The following study consisted of 6089 COVID-19 patients (median age: 45.9 [27.8.1–62.7] years; 50% male), of which 142 were cancer subjects","No Matching.",NA,"Median","63.82","IQR","51.01–78.62","45.07","142","Median","45.22","IQR","27.62–62.33","49.87","5947","Not mentioned",NA,"","","","","",NA,"","","54","38.02","845","14.2","cOR","3.71","2.62 - 5.24","0","11","7.74","132","2.21","cOR","3.7","1.95 - 7.01","0.00007","","","","","",NA,"","","9","6.33","112","1.88","cOR","3.53","1.75 - 7.10","5e-04","3","2.11","29","0.48","cOR","4.4","1.33 - 14.63","0.0154","1","0.7","15","0.25","cOR","2.8","0.37 - 21.38","0.3245","6","4.22","75","1.26","cOR","3.45","1.48 - 8.07","0.0042","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"systemic embolism 1, gastrointestinal bleeding 12, obesity 1, dementia and alzheimer's 3, heart failure 1, atrial fibrillation 5, ventricular tachycardia/fibrillation 3, acute MI 6, ischaemic heart disease 16, peripheral vascular disease 2","systemic embolism 0.7, gastrointestinal bleeding 8.45, obesity 0.7, dementia and alzheimer's 2,11, heart failure 0.70, atrial fibrillation 3.52, ventricular tachycardia/fibrillation 2.11, acute MI 4.22, ischaemic heart disease 11.26, peripheral vascular disease 1.4","systemic embolism 16, gastrointestinal bleeding 103, obesity 23, dementia and alzheimer's 22, heart failure 31, atrial fibrillation 84, ventricular tachycardia/fibrillation 28, acute MI 68, ischaemic heart disease 180, peripheral vascular disease 25","systemic embolism 0.26, gastrointestinal bleeding 1.73, obesity 0.38, dementia and alzheimer's 0.36, heart failure 0.52, atrial fibrillation 1.41, ventricular tachycardia/fibrillation 0.47, acute MI 1.14, ischaemic heart disease 3.02, peripheral vascular disease 0.42","","","","","CVD has been separated out in ""others""  Chronic lung disease = COPD  Cerebrovascular disease = stroke/TIA","","","",NA,"Self-calculated","Self-calculated","Self-calculated","","The primary outcome was a composite endpoint  of patients who required intubation, required intensive care unit (ICU) admission and/or suffered 30-day mortality.","30 day mortality; no definition ","The primary outcome was a severe composite endpoint of requirement for intubation, ICU admission and 30-day mortality.","univariate; multivariate","Age; Sex; Comorbidities; Other: multivariate analysis is also adjusted for medication treatments ",NA,"lung 9","","","","","","","","","","","","","aHR","3.19","0.88 - 11.54","0.0766","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","27","","","","","","","","","","","","","aHR","2.73","0.76 - 9.79","0.1222","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","gastrointestinal 14","","","","","","","","","","",NA,NA,"aHR","3.79","1.12 - 12.88","0.0325","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","",NA,NA,"colorectal 11","","","","","","","","","","","","","aHR","5.07","1.5 - 17.17 ","0.0091","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"genitourinary 8","","","","","","","","","","","","","aHR","2.63","0.67 - 10.31","0.1659","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","85","","","","","","","","","","","","","aHR","1.34","0.58 - 3.11","0.4897",NA,NA,"outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"154","","","","","","","","","","","","","aHR","3.77","1.63 - 8.72 ","0.0019","","","outcome = severe COVID-19 composite outcome in hospitalized patients; Composite outcome of intubation ICU admission and/or 30-day mortality","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"74954","Kodde 2023","Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network","Consensus","Peer-reviewed","Infection","QlikView","2022-06-03","Mortality in cancer patients with SARS‑CoV‑2 or seasonal influenza:  an observational cohort study from a German‑wide hospital network","Kodde C","Retrospective","Cohort","Yes","inpatient","Germany","","Helios group hospitals (85)","2020-01","2021-08","36726","Mortality, mechanical ventilation","","Severity; Mortality","no","The cancer cohort was defined by the presence of any of the three related Elixhauser comorbidities (lymphoma, meta- static cancer, solid tumor).","Same hospital group","No matching",NA,"Mean","72.2","SD","11.8","58.2","1625","Mean","68.0","SD","17.6","52.1","27659","Not mentioned",NA,"","","","","",NA,"","","952","58.6%","","","",NA,"","","487","29.9%","","","",NA,"","","402","24.7","","","",NA,"","","","","","","",NA,"",NA,"116","7.1%","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Mechanical ventilation","Not specified","In-hospital mortality; cause undefined","","univariate; multivariate","Age; Sex; Comorbidities; Other: comorbidities: Elixhauser index",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1625","mOR","2.10","1.88-2.35","<0.01","0.349 (530/1519)","0.203 (5483/27015)","","","","","0.294 (477/1625)","0.276 (8076/29284)","mOR","0.82","0.72-0.94","<0.01","","","","","","","","","","",NA,"1391","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"629","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"73804","Starkey 2023","A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","Consensus","Peer-reviewed","Nature Scientific Reports","National Cancer Registry UK and National Immunisation Management Service (NIMS)","2023-07","A population‑scale temporal case–control evaluation of COVID‑19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","Starkey, T","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","England","Population Scale (England)","Population Scale (England)","2020-11-01","2022-08-31","15928326","Hospitalisation, ICU, COVID-19 mortality","Hospital assessment","Hospitalisation; ICU admission; Mortality","yes","1. All cancer types  2. On national cancer registry UK  3. Active treatment not stated ","Same National Cohort (National Immunisation Management Service (NIMS) of the UK)","Not matched.",NA,"","","","","50.48","127322","","","","","43.05","15801004","Other: ORs and base rates are given for each of the four outcomes for each two month period so could be used to generate these figures",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Any of: hospital assessment, inpatient hospitalisation, intensive care  admission, COVID-19 mortality","physical ICU admission (not just IMV)","SARS-COV-2-mortality","","multivariate","Age; Sex; Other: age, sex, ethnicity and deprivation.",NA,"","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","12.13;4.43;18.55;4.97","8.62-17.08;3.04-6.44;16.75-20.55;4.45-5.56","<0.00001;<0.00001;<0.00001;<0.00001","","","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","13.5;6.47;5.58;2.53","6.40-28.45;2.88-14.51;3.70-8.42;1.64-3.89","<0.00001;<0.00001;<0.00001;0.00003","","","","","","","","","","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","9.55;3.60;7.28;3.39","8.83-10.33;3.32-3.92;5.71-9.28;2.60-4.41","<0.00001;<0.00001;<0.00001;<0.00001","","","","","uOR;mOR","2.53;1.66","2.23-2.88;1.45-1.91","<0.00001;<0.00001","","","uOR;mOR","0.56;0.58","0.29-1.07;0.29-1.16","0.07973;0.12508","","","","","","","","","","uOR;mOR","1.78;1.14","1.64-1.93;1.05-1.24","<0.00001;0.00308","","","","","uOR;mOR (includes small bowel and hepatobiliary)","17.34;5.85","15.22-19.76;5.08-6.74","<0.00001;<0.00001","","","uOR;mOR (includes small bowel and hepatobiliary)","1.51;0.78","0.56-4.02;0.29-2.09","0.41298;0.62780",NA,NA,"",NA,"",NA,"","","","uOR;mOR (including small bowel and hepatobiliary)","7.48;3.17","6.72-8.33;2.83-3.55","<0.00001;<0.00001","",NA,NA,"","uOR;mOR (colorectal only)","8.11;2.36","7.31-9.00;2.10-2.64","<0.00001;<0.00001","","","uOR;mOR (colorectal only)","4.91;2.76","3.60-6.71;2.01-3.79","<0.00001;<0.00001","","","","","","","","","","uOR;mOR (colorectal only)","4.49;2.01","4.17-4.84;1.86-2.18","<0.00001;<0.00001","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract","2.19;2.76;4.76;1.08; 8.99;1.86","1.27-3.78;1.54-4.95;4.30-5.28;0.97-1.20;7.89-10.23;1.62-2.15","0.00502;0.00069;<0.00001;0.18331;<0.00001;<0.00001","","","uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract","1.95;2.13;2.38;0.89;4.18;1.80","0.49-7.80;0.53-8.53;1.69-3.36;0.61-1.28;2.69-6.49;1.13-2.86","0.34593;0.28740;<0.00001;0.52082;<0.00001;0.01341","","","","","","","","","","uOR;mOR of male urological;uOR;mOR of prostate; uOR;mOR of urinary tract","1.65;2.04;3.19;1.25;4.93;1.78","1.19-2.29;1.43-2.90;2.98-3.41;1.16-1.34;4.49-5.41;1.61-1.97","0.00271;0.00007;<0.00001;<0.00001;<0.00001;<0.00001","","","","","uOR;mOR","4.32;2.80","3.61-5.18;2.30-3.41","<0.00001;<0.00001","","","uOR;mOR","2.06;1.78","1.11-3.84;0.96-3.31","0.02220;0.06927","","","",NA,"",NA,"","",NA,"uOR;mOR","2.64;1.77","2.34-2.98;1.56-2.02","<0.00001;<0.00001","","",NA,"","uOR;mOR","9.94;11.35","7.26-13.61;7.93-16.23","<0.00001;<0.00001","","","uOR;mOR","4.05;4.37","1.30-12.60;1.40-13.60","0.01554;0.01098",NA,NA,NA,NA,NA,NA,NA,NA,NA,"uOR;mOR","4.64;4.02","3.64-5.92;3.07-5.28","<0.00001;<0.00001","",NA,NA,"","uOR;mOR","5.32;2.79","4.03-7.03;2.08-3.74","<0.00001;<0.00001","","","uOR;mOR","7.77;5.24","4.50-13.41;3.03-9.06","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","3.86;2.24","3.24-4.60;1.86-2.70","<0.00001;<0.00001","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","uOR;mOR","10.43;4.08","8.08-13.47;3.09-5.39","<0.00001;<0.00001","","","uOR;mOR","2.80;1.78","0.90-8.71;0.57-5.52","0.07451;0.32148",NA,NA,NA,NA,NA,NA,NA,NA,NA,"uOR;mOR","5.02;2.51","4.12-6.11;2.03-3.11","<0.00001;<0.00001",NA,NA,NA,"","uOR;mOR","6.42;2.27","6.15-6.71;2.17-2.38","<0.00001;<0.00001","","","uOR;mOR","2.77;1.64","2.38-3.23;1.39-1.92","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","3.67;1.80","3.56-3.78;1.74-1.86","<0.00001;<0.00001","","","","","uOR;mOR","11.46;4.27","10.57-12.42;3.91-4.66","<0.00001;<0.00001","","","uOR;mOR","13.05;7.70","10.96-15.54;6.43-9.22","<0.00001;<0.00001","","","","","","","","","","uOR;mOR","7.82;4.12","7.41-8.25;3.89-4.37","<0.00001;<0.00001","","","","","uOR;mOR of endocrine glands","1.92;2.29","1.15-3.19;1.30-4.04","","","","uOR;mOR of endocrine glands","1.48;0.00","0.37-5.93;0.00-5.11E+46","0.57912;0.87726","","","",NA,"",NA,NA,NA,"","uOR;mOR of endocrine glands","1.91;2.00","1.46-2.49;1.50-2.66","<0.00001;<0.00001","","","",NA,"uOR;mOR",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"127322","uOR;mOR","7.12;2.54","6.85-7.40;2.44-2.65","<0.00001;<0.00001","0.0752; 0.0752","0.00715; 0.00715","uOR;mOR","4.22;2.53","3.76-4.74;2.24 - 2.86","<0.00001;<0.00001","0.00892;0.00892","0.00229;0.00229","","","","","","","","uOR;mOR","4.22;2.10","4.11-4.33;2.04 - 2.16","<0.00001;<0.00001","0.128;0.128","0.0261;0.0261","",NA,"","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","3.68;1.38;4.55;1.75;8.22;2.66","3.31-4.09;1.23-1.54;4.03-5.14;1.54-1.99;7.44-9.08;2.39-2.95","<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001","","","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","1.89;1.12;3.32;2.11;1.70;0.86","1.33-2.69;0.77-1.63;2.37-4.65;1.48-3.01;1.02-2.82;0.51-1.46","0.00042;0.53783;<0.00001;0.00004;0.04105;0.58374","",NA,NA,NA,NA,NA,"",NA,"","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","2.62;1.29;3.12;1.57;4.46;2.01","2.46-2.80;1.21-1.39;2.88-3.37;1.44-1.70;4.15-4.79;1.86-2.16","<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001","",NA,NA,"","uOR;mOR","19.71;6.66","17.69-21.97;5.90-7.52","<0.00001;<0.00001","","","uOR;mOR","8.36;3.98","5.79-12.05;2.70-5.87","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR ","7.66;3.57","6.98-8.40;3.24-3.94","<0.00001;<0.00001","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","uOR;mOR","11.58;7.69","10.81-12.40;7.13-8.29","<0.00001;<0.00001","","","uOR;mOR","7.53;5.51","6.20-9.15;4.50-6.74","<0.00001;<0.00001","","","","","",NA,"","","","uOR;mOR","6.29;4.14","5.98-6.61;3.92-4.36","<0.00001;<0.00001","","","","","","uOR;mOR","11.32;3.17","7.36-17.40;2.03-4.95","<0.00001;<0.00001","","","uOR;mOR","2.85;1.21","0.40-20.25;0.17-8.63","0.29636;0.84867",NA,NA,"","","",NA,"",NA,NA,"uOR;mOR","9.18;4.07","6.86-12.27;3.00-5.53","<0.00001;<0.00001",NA,NA,NA,"","","uOR;mOR","20.61;14.12","16.38-25.93;10.93-18.25","<0.00001;<0.00001","","","uOR;mOR","28.91;21.97","18.73-44.62;14.17-34.05","<0.00001;<0.00001","","","",NA,NA,NA,"",NA,"B/T-cell antibody therapy","uOR;mOR","13.03;9.38","11.02-15.41;7.83-11.24","<0.00001;<0.00001","","","","","","uOR;mOR","8.12;4.29","7.38-8.93;3.88-4.76","<0.00001;<0.00001","","","uOR;mOR","3.68;2.53","2.65-5.10;1.81-3.56","<0.00001;<0.00001","","","","","",NA,"","","","uOR;mOR","4.17;2.39","3.88-4.47;2.21-2.57","<0.00001;<0.00001","","","","","","uOR;mOR","11.10;3.76","6.99-17.63;2.32-6.10","<0.00001;<0.00001","","","uOR;mOR","0.00;0.00","0.00-1.95E+37;0.00-1.37E+36","0.87403;0.86020","","","","","",NA,"",NA,NA,"uOR;mOR","7.56;3.06","5.64-10.12;2.26-4.15","<0.00001;<0.00001","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"15928326","100","uOR;mOR","7.12;2.54","6.85-7.40;2.44-2.65","<0.00001;<0.00001","","","uOR;mOR","4.22;2.53","3.76-4.74;2.24-2.86","<0.00001;<0.00001","","","","","","","","","","uOR;mOR","4.22;2.53","3.76-4.74;2.24-2.86","<0.00001;<0.00001","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"cancer: 156187; non-cancer:14028232","cancer: 78.56%; non-cancer:77.13%","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"1+ Dose","cancer: 42632; non-cancer: 4160341","cancer: 21.44%; non-cancer:22.87%","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"0 Doses","no"
"73383","Hosseini-Moghaddam 2023","SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer","Consensus","Peer-reviewed","JAMA Network Open","COVID-19 Integrated Testing Database; Ontario Registered Persons Database; Canadian Institute for Health Information's Discharge Abstract Database.","2023-08","SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer","Hosseini-Moghaddam, S M","Retrospective","Cohort","Yes","outpatient","Canada","Ontario","","2020-01-01","2021-12-31","464574","COVID-19 infection positivity.","Hospitalisation, ICU admission and mortality.","Hospitalisation; ICU admission; Mortality","yes","All Types Cancer; active treatment in last 6 months or diagnosis in OCR within past year before index ","Drawn from same national cohort. ","No Matching; ratio cancer:non cancer 8378:456196",NA,"Mean","59.61","SD","18.05","40.6","8378","Mean","45.95","SD","18.24","48.96","456196","Not mentioned",NA,"","","","","",NA,"","","4219","50.4","108968","23.9","cOR","3.23","3.10-3.38 ","","2475","29.5","69480","15.2","cOR","2.33","2.23-2.45","","1499","17.9","26250","5.8","cOR","3.57","3.37-3.78","","207","2.5","4248","0.9","cOR","2.7","2.34-3.10",NA,"124","1.5","1102","0.2","cOR","6.2","5.15-7.48","","779","9.3","11959","2.6","cOR","3.81","3.53-4.11","","2035","24.3","83958","18.4","cOR","1.42","1.35-1.50","","128","1.5","1715","0.4","cOR","","","",NA,NA,NA,NA,"",NA,"",NA,"88; 647","1.1; 7.7","2797; 16094","0.6; 3.5","cOR","1.72; 2.29","1.39-2.13; 2.11-2.48","","IBD; Dementia  taken from eTable4 in supps","IBD; Dementia   taken from eTable4 in supps","IBD; Dementia  data taken from eTable2 and cancer data from eTable4 has been subtracted to get non-cancer cohort data","IBD; Dementia",NA,"IBD; Dementia","IBD; Dementia","I calculated crude OR and CI and have left p-values for James as discussed","","21-day ICU admission","28-day mortality; covid-19 specific mortality  ","","univariate; multivariate; Other: Crude","Age; Sex; Comorbidities; Other: Past healthcare utilisation, income, rurality, PHU region, Ontario Marginalisation Index, 2016 Canada census variables.",NA,"321","","","","","0.178 (57/321)","","","","","","","","","","","","","","","","","","","0.312 (100/321)","","","1272","","","","","0.061 (78/1272)","","","","","","","","","","","","","","","","","","","0.134 (171/1272)","","","132","","","","","0.106 (14/132)","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","0.257 (34/132)",NA,NA,"676","","","","","0.095 (64/676)","","","","","","","","","","","","","","","","","","","0.204 (138/676)","","","71","","","","","0.113 (8/71)","","","","","","","","","","","","","","","","","","","0.225 (16/71)","",NA,"271","","","","","0.077 (21/271)","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"0.155 (42/271)","",NA,"1336","","","","","0.099 (132/1336)","","","","","","","","","","","","","","","","","","","0.208 (278/1336)","","","1797","","","","","0.015 (27/1797)","","","","","","","","",NA,"",NA,"","",NA,"","","","","0.0573 (103/1797)","",NA,"47","","","","","0.128 (6/47)","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","0.255 (12/47)",NA,NA,"698","","","","","0.016 (11/698)","","","","","","","","",NA,"",NA,"","","","","","","","0.113 (79/698)","",NA,"125","","","","","0.080 (10/125)","","","","","","","","","","","","","",NA,"","","","","0.096 (12/125)","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"7185","aHR","1.31","1.19-1.44","","0.066 (475/7185)","","aHR","0.93","0.82-1.05","","0.366 (388/1060)","","",NA,"",NA,"","","","aHR","1.11","1.05-1.18","","0.148 (1061/7185)","","adjusted HRs taken from eTable10 in supps","1193","aHR","2.04","1.74-2.38","","0.137 (163/1193)","","aHR","1.14","0.93-1.40","","0.405 (130/321)","","","","","","","","","aHR","1.75","1.57-1.96","","0.269 (321/1193)","","adjusted HRs taken from eTable10 in supps","439; 357","","","","","0.107 (47/439); 0.151 (54/357)","","","","","","","","",NA,"",NA,NA,NA,"","","","","","0.173 (76/439); 0.303 (108/357)","","other solid tumour; other haematological malignancy ",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"8378","","","","","","0.0466 (21267/456188)","","","","","","0.345 (10207/29582)","","","","","","","non-cancer EVENT/TOTAL taken from graphs in figure 1. We have subtracted number survived at end of period from number survived at start of period to get number who died.   cancer EVENT/TOTAL taken from eTable11 in supps","","","","","","0.094 (42886/456034)","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"43046","9.3","aHR (1 dose); aHR ( >2 dose)","0.57; 0.50","0.51-0.63; 0.45-0.57","","","","aHR (1 dose); aHR ( >2 dose)","0.76; 0.74","0.68-0.85; 0.63-0.87",NA,"","","","","",NA,NA,NA,"aHR (1 dose); aHR ( >2 dose)","0.68; 0.42","0.64-0.71; 0.39-0.46",NA,NA,NA,"raw data taken from supps eTable2. Vaccinated is sum of dose 1, dose 2 and dose 3. Data taken for covid-19 positive cohort   HRs taken from eTable10 (1dose; >2 dose). Note: it is not comparing cancer to non-cancer but vaccinated to unvaccinated so data may not be relevant ","421528","90.7","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"72854","Konermann 2023","High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.(rerun)","Consensus","Peer-reviewed","Oncology Research and Treatment","ClinicalTrials.gov, NCT04659187","2023-02","High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study","Konermann F M","Prospective","Cohort","Yes","inpatient","Germany","N/A","The hospital network Asklepios","2020-03-11; 2020-03-11 (WT to Delta); 2022-01-01 (Omicron)","2022-07-20; 2022-01-01 (WT to Delta); 2022-07-20 (Omicron)","26425","""Survival status at discharge from hospital is the primary end-point of the investigation."" ","""Additionally, we differentiated patients with solid and hematological malignancies with regard to the primary endpoint.""","Mortality","no","1. All cancer types, 2. Active diagnosis of cancer with ICD-10 codes C00-C97, 3. No statement on treatment ","Same country, but involved multiple centers across Germany","Not matched",NA,"Active Cancer/ WT-D; Active Cancer/Omicron  Median","75; 74","IQR","65 - 82; 64 - 81","58; 62","1513","No Cancer/WT-D; No Cancer/Omicron  Median","70; 72","IQR","54 - 82; 53 - 83","52; 49","24912","Wild Type (Ancestral/Wu-1); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"","","","","",NA,"","","","","","","",NA,"","","166 (Active Cancer/ WT-D);  138(Active Cancer/Omicron)","21; 19","3644(No Cancer/WT-D);1890(No Cancer/Omicron)","24; 19","",NA,"","","120 (Active Cancer/ WT-D); 103 (Active Cancer/Omicron)","15; 14","1962(No Cancer/WT-D); 1342(No Cancer/Omicron)","13; 14","",NA,"","","45 (Active Cancer/ WT-D); 33(Active Cancer/Omicron)","5.8; 4.5","997(No Cancer/WT-D); 676(No Cancer/Omicron)","6.6; 6.8","",NA,"",NA,"11 (Active Cancer/ WT-D); 15(Active Cancer/Omicron)","1.4; 2.0","94(No Cancer/WT-D); 85(No Cancer/Omicron)","0.6; 0.9","",NA,"","","136 (Active Cancer/ WT-D); 110 (Active Cancer/Omicron)  ","18; 15","2332(No Cancer/WT-D); 1334(No Cancer/Omicron)","16; 13","",NA,"","","99( Active Cancer/ WT-D); 73(Active Cancer/Omicron)","13; 9.9","1396 (No Cancer/WT-D); 842(No Cancer/Omicron)","9.3; 8.5","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"127 (Dyslipidemia Active Cancer/ WT-D); A95 (Dyslipidemia active Cancer/Omicron) 29 (Obesity Active Cancer/ WT-D); 19 (Obesity Active Cancer/Omicron)","16 (Dyslipidemia); 13 (Dyslipidemia) 3.7 (Obesity); 2.6 (Obesity) ","2334 (Dyslipidemia No Cancer/WT-D); 1521 (Dyslipidemia No Cancer/Omicron)  992 (Obesity No Cancer/WT-D); 382(Obesity No Cancer/Omicron)","16 (Dyslipidemia No Cancer/WT-D); 15 (Dyslipidemia No Cancer/Omicron) 6.6 (Obesity No Cancer/WT-D); 3.9 (Obesity No Cancer/Omicron)","","","","","","","","",NA,"","","","Mechanical ventilation (intubation)","","Death in-hospital","","multivariate","Sex; Comorbidities",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"1172","cOR","NR","NR","NR","0.234 (274/1172)","0.220 (2000/9089)","","","","","","","",NA,"",NA,"","","","","","","","","","","341","cOR","NR","NR","NR","0.237 (81/341)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1513","mOR","1.685","1.686 - 2.064","NR","0.235 (355/1513)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"WT/D cancer patients 777","51.4 of cancer patients","mOR","1.94","1.646 - 2.285","NR","0.272 (211/777)","0.161 (2418/14998)",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"736 cancer patients","48.6 of cancer patients","mOR","2.864","2.354 - 3.486","NR","0.196 (144/736)","0.0783 (776/9914)",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"1513","100","cOR","","","","0.235 (355/1513)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"72593","Anantharaman 2021","SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California(rerun)","Consensus","Peer-reviewed","The Oncologist ","","2020-12","SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California","Anantharaman, A","Retrospective","Cohort Study","Yes","inpatient and outpatient (no breakdown)","USA","Northern California ","n/a","2020-02-25","2020-06-08","4627","Emergency department visit, inpatient hospitalisation, ICU stay, mechanical ventilation, non invasive ventilation and mortality between Covid-19 diagnosis and first 45 days of diagnosis or end of study","Distinct primary and secondary outcomes not stated","Severity; Hospitalisation; ICU admission; Mortality; Other: ED visit, non invasive ventilation ","no","All Types Cancers; Patients having active treatment for cancer in the 180 days prior to COVID-19 diagnosis; On active treatment","Adults with positive lab test for Covid-19 with no cancer history. Adults with positive lab test for Covid-19 with history of cancer in Kaiser Permanente Northern California (KPNC) cancer registry but no active treatment cancer in 180 days prior to Covid-19 diagnosis and no history of cancer.   N.b.Adjusted ORs calculated adjusting for demographic and clinical characteristics (cancer history, age, sex, race/ethnicity, body mass index, charlson comorbidity index, hypertension, diabetes, smoking status, neighbourhood deprivation index) and week of Covid-19 diagnosis to account for changing testing and treatment guidelines. ","No matching",NA,"","","Age groups","18-59: 39%; 60-69: 24%; 70+: 36%","45%","33","","","Age groups","18-59: 77%; 60-69: 13%; 70+: 10%","48%","4380","Not mentioned",NA,"","39","","25","",NA,"","","","42","","13","",NA,"","","","18","","13","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Invasive mechanical ventilation","","45-day mortality; Cause not stated","Requiring invasive mechanical ventilation","multivariate","Age; Sex; Comorbidities; Other: cancer history, age, sex, race/ethnicity, body mass ass index, Charlson comorbidity index, hypertension, diabetes, smoking status, and neighborhood deprivation index and week of COVID-19 diagnosis",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","9","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"33","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.30","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","Severity = invasive ventilator ","mOR","1.55","0.67-3.59","NR","NR","NR","No p values or absolute numbers stated. Also have pooled outcomes, ED visit, non invasive ventilation cancer vs non cancer if relevant.",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","33","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.30","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","","mOR","1.55","0.67-3.59","NR","NR","NR","",NA,"12","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","11","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"14","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"4413","100","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.30","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","","mOR","1.55","0.67-3.59","NR","NR","NR","NR","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"71915","Leuva 2022","Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.","Consensus","Peer-reviewed","Seminars in Oncology","A COVID-19 Shared Data Resource (CSDR) data using the Veterans Administration Informatics and Computing Infrastructure (VINCI).","2022-07","Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans","Leuva, H","Prospective","Cohort","Yes","inpatient","USA","","N/A"," 2020-12-14","2022-01-25 ","21,051","Death within 60 days in the Covid Infected, COVID infection rate","","Mortality; Other: Covid-19 infection","yes","All Types Cancer; Veterans with an active diagnosis of new or previously established cancer in the 2 years preceding the index date; active treatment not stated","Yes - Gender, Comorbidity and age matched - see supplementary table 2 157,072 Cancer: 157,072 Control - 1:1 Matching","Matched; 1:1; age, sex, comorbidity",NA,"Median (not vaccinated); Median (vaccinated)","72 (not vaccinated); 72 (vaccinated)","IQR (not vaccinated); IQR (vaccinated)","64-76 (not vaccinated); 67-76 (vaccinated)","94% (not vaccinated), 95%(vaccinated)","10355","Median (not vaccinated); Median (vaccinated)","72 (not vaccinated); 73 (vaccinated)","IQR (not vaccinated); IQR (vaccinated)","64-76 (not vaccinated); 68-77(vaccinated)","94% (not vaccinated), 95% (vaccinated)","10696","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","60 day mortality; all-cause ","","univariate; multivariate","Age; Sex; Comorbidities; Other: age, gender, race, BMI, smoking, rurality of normal residence, Elixhauser index and time during the pandemic",NA,"728","aOR","1.955","1.486-2.572","<0.0001","0.095(69/728)","0.048(509/10696)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"475","aOR","1.458","0.98-2.170",">0.001","0.061(29/475)","0.048(509/10696)","","","","","","","","","","","","","","","","","","","","Colon Cancer","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"3224","aOR","0.698","0.559-0.870",">0.001","0.032(102/3224) ","0.048(509/10696)","","","","","","","","","","","","","","","","","","","","Prostate","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"8513","aOR","0.960","0.835-1.105",">0.001","0.043(370/8513)","0.048(509/10696)","","","","","","","",NA,"",NA,"","","","","","","","","","","1842","aOR","2.154","1.788-2.597","<0.0001","0.095(175/1842)","0.048(509/10696)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"10355","aOR","1.168","1.028-1.326","p>0.001","0.052 (545/10355)","0.048(509/10696)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","10355","aOR","1.168","1.028-1.326 ",">0.001","0.052 (545/10355) ","0.048(509/10696)","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"10355","100","aOR","1.168","1.028-1.326 ",">0.001","0.052 (545/10355) ","0.048(509/10696)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"10355","","aOR","1.168","1.028-1.326",">0.001","0.050 (545/10355)","0.048(509/10696)","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","12884","","aOR","0.934","0.861-1.012",">0.001","0.100 (1310/12884)","0.102(1310/12884)",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"71633","Raad 2023","International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.","Consensus","Peer-reviewed","eLife","","2023-01","International multicenter study  comparing COVID-19 in patients with  cancer to patients without cancer: Impact  of risk factors and treatment modalities  on survivorship","Raad I. I.","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","Australia, Brazil, France, Japan, Lebanon, Singapore, South Korea, Spain, USA","","","2020-01-04","2020-11-15","3966","30 day mortality","Hospital readmissions within 30 days after  COVID-19 diagnosis, mechanical ventilation, progression to lower respiratory tract infection, co-infection","Hospitalisation; ICU admission; Mortality","Other: No","All types cancer; diagnosed or treated within 1 year before the diagnosis of COVID-19; active treatment not stated","Same multinational cohort","Matched; 1:2.56; country",NA,"Median","61","Range","18-100","45","1115","Median","50","Range","18-100","47","2851","Not mentioned",NA,"409","38","348","17","",NA,"","<0.0001","546","49","1020","36","",NA,"","<0.0001","299","27","6599","23","",NA,"","<0.0001","85","12","240","12","",NA,"","<0.001","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","75","7","175","9","","","","0.07","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","","","multivariate","Age; Other: Country, tocilizumab treatment, convalescent plasma treatment",NA,"64","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"632","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","283","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1115","mOR (multiple imputations)","1.23","0.87-1.75","0.24","","","cRR","(141/1100)/(225/1846)=1.05","","0.62","141/1100","225/1846","","","","0.98","135/1096=12.3%","130/1052=12.4%","","cRR","(63/481)/(60/806)=1.76","","<0.0001","63/481=13.1%","60/806=7.44%","Hospitalisation referred to hospital re-admission within 30 days of COVID-19 diagnosis",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"71628","Turtle 2023","Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.","Consensus","Peer-reviewed","PLOS Medicine"," ISARIC WHO Clinical Characterisation Protocol UK prospective observational cohort study (ISARIC4C)","2023-01","Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study","Turtle L","Prospective","Cohort","Yes","inpatient","United Kingdom","N/A","N/A","2020-01-17; 2020-01-17 (wave 1/D614G); 2020-09-01 (wave 2/Alpha); 2021-04-01 (wave 3/Delta); 2021-12-13 (wave 4/Omicron)","2022-02-28; 2020-08-31 (wave 1/D614G); 2021-03-31 (wave 2/Alpha); 2021-12-12 (wave 3/Delta); 2022-02-28 (wave 4/Omicron)","139714","In-hospital mortality ","4C mortality score - illness severity at presentation until 28 days after admission   In-hospital interventions: Use of oxygen  Noninvasive ventilation  Invasive mechanical ventilation  Admission to critical care ","Severity; ICU admission; Mortality","yes","All Types Cancer; ""Active cancer diagnosis""; on active treatment","Drawn from the same multinational cohort  Includes patients with a 'history of malignant neoplasm'","No matching; No matching ratio",NA,"median","72.0","IQR","62.0-79.7","58.1","5116","median","69.5","IQR","53.4-82.0","55.3","134598","Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"1621","31.7","33798","25.1","",NA,"","","2049","40.1","57117","42.4","",NA,"","","1188","23.2","36322","27.0","",NA,"","","1318","25.8","35597","26.4","",NA,"","","","","","","",NA,"",NA,"229","4.5","3800","2.8","",NA,"","","790","15.4","18901","14.0","",NA,"","","946","18.5","18495","13.7","","","","","5116","100","0","0","","","","",NA,NA,NA,NA,"",NA,"",NA,"Asthma;chronic neurological disorder;chronic haematologic disease;dementia;malnutrition;Rheumatologic disease 511;385;1132;160;559","10;7.5;22.1;5.6;3.1;10.9","17720;13957;3665;15328;2417;12901","13.2;10.4;2.7;11.4;1.8;9.6","","","","","","","","",NA,"","","","4C Mortality Score","Critical care admission ","28 day mortality; all cause","Non-invasive or invasive ventilation required, 4C mortality score (respiratory rate (breaths per min), Glasgow Coma Scale, oxygen saturation (%), blood urea (mmol/L), blood C-reactive protein (CRP, mg/L)","multivariate","Age; Sex; Comorbidities; Other: Ethnicity, deprivation index, vaccination, ",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"5116","mOR","2.00","1.87-2.15","<0.001","0.355 (1818/5116)","0.213 (28608/134598)","mOR","0.77","0.70-0.85","<0.001","0.867 (4437/5116)","0.154 (20710/134598)","mOR;mOR","0.93;0.65","0.86-1.01;0.56-0.76","0.095;<0.001","0.179 (918/5116);0.0461(236/5116)","0.182 (24445/134598);0.0644 (8665/134598)","Noninvasive;invasive","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5116","mOR","2.00","1.87-2.15","<0.01","0.365 (1818/5116)","0.219 (28608/134598)","mOR","0.77","0.70-0.85","<0.001","0.873 (4437/5116)","0.155 (20710/134598)","mOR;mOR","0.93;0.65","0.86-1.01;0.56-0.76","0.095;<0.001","0.182 (918/5116);0.047(236/5116)","0.185 (24445/134598);0.066 (8665/134598)","Noninvasive;invasive","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","mOR","1.28","1.20-1.36","<0.001","","",NA,NA,NA,NA,"","","",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","mOR","0.83","0.76-0.91","<0.001","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,NA,NA,"","","mOR","0.66","0.54-0.80","<0.001","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","Alpha","","mOR","1.19","1.12-1.26","<0.001","","",NA,NA,NA,NA,"","","","","","","","","Alpha: Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","yes"
"71512","Nolan 2023","Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.","Consensus","Peer-reviewed","CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION","COVID EHR Cohort","2023-01","Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin","Nolan, M. B.","Retrospective","Cohort","Yes","inpatient","USA","","Duke University, Hackensack Meridian Health, Mayo Clinic (3 locations: Phoenix, AZ, Jacksonville, FL, Rochester, MN), Memorial Sloan Kettering Cancer Center, Mount Sinai, New York University, Northwestern University, University of California-Davis, University of California-San Francisco, University of Chicago, University of Illinois at Chicago, University of Kansas, University of Maryland, University of Michigan, University of North Carolina, University of Utah, University of Wisoconsin, Vanderbilt University, Virginia Commonweatlth University, Washington University, Yale University","2020-02-01","2021-09-30","104590","in-hospital mortality and ICU admission","","ICU admission; Mortality","yes","All Types Cancer; Any ICD-10 cancer diagnosis recorded during the index COVID-19 hospitalisation; Active treatment not stated.","same databases","No matching",NA,"","","","","55.0","7141","","","","","49.2","90700","Not mentioned",NA,"3616","50.6","33647","36.9","",NA,"","0.079","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","icu admission","In-hospital mortality (no further definition stated)","","multivariate","Age; Sex; Comorbidities; Other: BMI",NA,"732","uOr; mOR","2.47; 1.93","2.04-2.99; 1.59-2.36","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","611","uOr; mOR","1.47; 1.57","1.14-1.88; 1.21-2.03","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"1062","uOr; mOR","1.70; 1.40","1.42-2.04; 1.17-1.69","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"628","uOr; mOR","1.88; 1.05","1.49-2.36; 0.83-1.33","<0.001; 0.66","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"2012 (metastatic); 2012 (metastatic); 4337 (solid tumour without metastasis);  4337 (solid tumour without metastasis)","uOR (metastatic); mOR (metastatic);  uOR (solid tumour without metastasis); mOR  (solid tumour without metastasis)","2.28 (metastatic); 1.94 (metastatic); 1.82 (solid tumour without metastasis); 1.48 (solid tumour without metastasis)","2.01-2.58 (metastatic); 1.71-2.21 (metastatic); 1.66-1.99 (solid tumour without metastasis); 1.35-1.62 (solid tumour without metastasis)","<0.001 (metastatic); <0.001 (metastatic); <0.001 (solid tumour without metastasis);  <0.001 (solid tumour without metastasis)","nr (metastatic); nr (metastatic); nr (solid tumour without metastasis); nr (solid tumour without metastasis)","0.092 (8384/90700) (metastatic); 0.092 (8384/90700) (metastatic); 0.092 (8384/90700) (solid tumour without metastasis); 0.092 (8384/90700) (solid tumour without metastasis)","","","","","","","",NA,"",NA,"","","","","","","","","","","2482","uOr; mOR","2.02; 1.71","1.80-2.26; 1.52-1.92","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"7141","uOr; mOR","1.91; 1.58","1.78-2.06; 1.46-1.70","<0.001; <0.001","0.146 (1040/7141); 0.146(1040/7141)","0.092 (8384/90700); 0.092 (8384/90700)","uOR; mOR","1.31; 1.24","1.24-1.39; 1.17-1.32","<0.001; <0.001","0.247 (1763/7141); 0.247(1763/7141)","0.199 (18063/90700); 0.199 (18063/90700)","","","","","","","","","","","","","","",NA,"4337","uOR; mOR","1.82; 1.48","1.66-1.99; 1.35-1.62","<0.001; <0.001","nr; nr","0.92 (8384/90700); 0.92 (8384/90700)","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"2012","uOR; mOR","2.28; 1.94","2.01-2.58; 1.71-2.21","<0.001; <0.001","nr; nr","0.92 (8384/90700); 0.92 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"6344 ","11.5","","","","","0.104 (76/733)","0.052 (252/4848)","","","",NA,"0.205 (150/733)","0.163 (790/4848)","","","",NA,NA,NA,"","","",NA,NA,NA,"","48639","88.5","",NA,"","","0.131 (403/3074)","0.076 (3237/42593)",NA,NA,NA,NA,"0.241 (741/3074)","0.182 (7752/42593)","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"71402","Salvatore 2023","COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination.","Consensus","Peer-reviewed","Cancer Epidemiology, Biomarkers & Prevention","Electronic health record data from Michigan Medicine (University of Michigan, Ann Arbor, MI)","2022-04","COVID-19 outcomes by cancer status, type, treatment, and vaccination","Salvatore, M","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","USA","Michigan","N/A","2020-03-10","2022-02-02","44410","COVID-19 related hospitalization, ICU admission, all-cause mortality, composite severe COVID (union of first three outcomes)","N/A","Hospitalisation; ICU admission; Mortality; Other: Composite outcome: covid-19 hospitalization, ICU admission, all-cause mortality","yes","Bladder, Breast, Colorectal, Kidney, Lung, Melanoma, Prostate and Haematological Cancers; diagnosed within the last 3 years; proportion on active treatment ","Those testing positive for COVID-19 and did not have cancer from the same electronic health record data from a large academic healthcare system (Michigan Medicine)","No Matching",NA,"","","","","","6143","","","","","","38267","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Composite score of covid-19 hospitalization, ICU admission, all-cause mortality","% of those admitted to ICU","60 day mortality; all-cause","unit (ICU) admission, mortality ","multivariate","Age; Sex; Comorbidities; Other: Neighborhood disadvantage index ",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"6143","mOR","1.68","1.39-2.04","","NR (NR/6143)","NR (NR/38267)","mOR","1.19","0.97-1.46","","NR (NR/6143) ","NR (NR/38267)","mOR","1.48","1.35-1.63","","NR (NR/6143) ","NR (NR/38267)","Composite Outcome as above ","mOR","1.43","1.29-1.58","","NR (NR/6143)","NR (NR/38267) ","most recent diagnosis within past 3 years",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6143","mOR","1.68","1.39-2.04","","NR (NR/6143)","NR (NR/38267) ","mOR","1.19","0.97-1.46","","NR (NR/6143)","NR (NR/38267)","mOR","1.48","1.35-1.63","","NR (NR/6143)","NR (NR/38267)","","mOR","1.43","1.29-1.58","","NR (NR/6143)","NR (NR/38267)","Most recent diagnosis within past 3 years",NA,"1168;537","19; 8.7","mOR;mOR","3.01;2.04","2.26-4.02;1.27-3.29","","NR (NR/1168); NR (NR/537)","NR (NR/38267); NR (NR/38267)","mOR;mOR","1.90;1.58","1.37-2.62;0.95-2.62","","NR (NR/1168); NR (NR/537) ","NR (NR/38267); NR(NR/38267)","mOR;mOR","2.90;1.68","2.49-3.38;1.30-2.16",NA,"NR (NR/1168); NR (NR/537)","NR (NR/38267); NR(NR/38267)","Most recent chemo within past year; most recent chemo one to 3 years ago ","mOR","2.75;1.59","2.34-3.22;1.22-2.08","","NR (NR/1168); NR (NR/537)","NR (NR/38267); NR (NR/38267)","Most recent chemo within past year; most recent chemo one to 3 years ago ","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"6143","100","mOR","1.68","1.39-2.04","","NR (NR/6143)","NR (NR/38267)","mOR","1.19","0.97-1.46","","NR (NR/6143)","NR (NR/38267)","mOR","1.48","1.35-1.63","","NR (NR/6143)","NR (NR/38267)","","mOR","1.43","1.29-1.58","","NR (NR/6143)","NR (NR/38267)","Most recent initial diagnosis Within past 3 years ","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","mOR; mOR;mOR","1.38, 1.54, 1.82","0.84-2.27, 1.09-2.18, 1.39-2.37",NA,NA,NA,"","","",NA,NA,NA,"partially vaccinated; fully vaccinated; boosted","","","",NA,"","","","",NA,NA,NA,NA,"","","mOR","1.2","1.10-1.31",NA,NA,NA,NA,NA,NA,NA,NA,NA,"before vaccination","no"
"70896","Abuhelwa 2022","In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States.","Consensus","Peer-reviewed","Cancers","the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) 2020 database","2022-12"," In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States ","Abuhelwa Z","Retrospective","Cohort","Yes","inpatient","USA","N/A","N/A","2020-01-01","2020-12-31","1050045","All-cause in-hospital mortality","(i) morbidity as measured by the rates of septic shock, acute respiratory failure, acute respiratory distress syndrome, and mechanical ventilation (ii) resource utilization as measured by length of hospital stay and total hospitalization charges.","Severity; ICU admission; Mortality","no","All cancer; active cancer, active treatment not stated","Patient with a COVID-19 diagnosis without a cancer diagnosis","Matched; 27760:1022285; age, sex, race, comorbidities",NA,"mean","70.92","95% CI","70.52-71.32","56.57","27760","mean","64.57","95% CI","64.41-64.74","52.7","1022285","Not mentioned",NA,"10110","36.42","273260","26.73","",NA,"","<0.001","19380","69.81","692565","67.75","",NA,"","<0.001","9585","34.53","419910","41.08","",NA,"","","6175","22.24","186725","18.27","",NA,"","<0.001","","","","","",NA,"",NA,"1320","4.76","44360","4.34","",NA,"","0.151","4790","17.26","150100","14.68","",NA,"","<0.001","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","No mention of CVD. I put in numbers of coronary artery disease.","","","",NA,"","","","N/A","Mechanical ventilation","Mortality; all cause","N/A","multivariate","Age; Sex; Comorbidities; Other: age, sex, race, admission type, admission day, hospital bed size, hospital teaching status, hospital region, insurance status, median annual income, and comorbidities.",NA,"4400","mOR","1.57","1.31-1.88","<0.001","0.209 (920/4400)","","","","","","","","","","","","","","lung","","","","","","","","3340","mOR","0.96","0.73-1.27","0.763","0.103 (345/3340)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"1675","mOR","1.45","1.07-1.96","0.015","0.191 (320/1675)","","","","","","","","","","","","","","colorectal","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"4080","mOR","0.94","0.77-1.14","0.533","0.190 (775/4080)","","","","","","","","","","","","","","prostate","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"13495","","","","","0.175 (2360/13495)","","","","","","","","",NA,"",NA,"","","","","","","","","","","13550","mOR;mOR;mOR","1.22;1.30;1.20","1.02-1.45;1.05-1.61;0.94-1.52","0.028;0.016;0.137","0.224;0.156;0.108","","","","","","","","","","","","","","leukemia;lymphoma;multiple myeloma","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"27760","mOR","1.21","1.12-1.31","<0.001","0.176 (4880/27760)","0.120 (122451/1022285)","mOR(mechanical_ventilation)","0.98","0.88-1.09","0.767","","","OR","0.93"," 0.8–1.07","0.31","0.499","0.522","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"70019","Klein 2021","Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19","Consensus","Peer-reviewed","The Oncologist","Medical record at  Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital ","2021-05","Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19","Klein I.A.","Retrospective","Cohort","Yes","inpatient","USA","Massachusetts","Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital","2020-03-13","2020-05-10","401","death or hospice admission during hospitalization for COVID-19","intubation and admission to the intensive care unit (ICU)","ICU admission; Mortality; Other: Hospice admission, intubation","no","Patients with a history of cancer were defined as those with a current diagnosis of, or a history of, invasive cancer or hematologic malignancy; patients with a history of noninvasive cancers, cutaneous squamous or basal cell carcinomas, or premalignant hematologic conditions were excluded.","Matched with the patients from the same databases (multi-hospital).","Matched; 1:2; age, admission date, sex, race",NA,"Median","69.0","range","30-98","56.2","77","Median","68.5","range","30-96","56.2","324","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","132","40.7","",NA,"","","","","111","34.3","",NA,"","","","","","","",NA,"",NA,"","","12","3.7","",NA,"","","","","83","25.6","",NA,"","","","","59","18.2","","","","","","","28","8.6","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","48","14.8","","","","","","","","",NA,"","","","","[]","In patient death or discharge to hospice; all cause","N/A","univariate; multivariate","Comorbidities",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"77","uOR;mOR","1.98; 2.18","0.99-3.96; 0.82-5.77","0.053; 0.12","","","uOR;mOR","0.53; 0.39","0.29-0.96; 0.17-0.89","0.03; 0.03","","","uOR;aOR","0.65;0.54","0.34-1.16;0.23-1.24","0.14;0.15","","","Primary outcome is defined as ""mortality OR admission to hospice"". Severity defined as ARDS","","","","","","","Table 4 and 5",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","77 (100%)","uOR;mOR","1.98; 2.18","0.99-3.96; 0.82-5.77","0.053; 0.12","","","uOR;mOR","0.53; 0.39","0.29-0.96; 0.17-0.89","0.03; 0.03","","","uOR;aOR","0.65;0.54","0.34-1.16;0.23-1.24","0.14;0.15","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"77","100%","uOR;mOR","1.98; 2.18","0.99-3.96; 0.82-5.77","0.053; 0.12","","","uOR;mOR","0.53; 0.39","0.29-0.96; 0.17-0.89","0.03; 0.03","","","uOR;aOR","0.65;0.54","0.34-1.16;0.23-1.24","0.14;0.15","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"69998","Serraino 2021","Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Consensus","Peer-reviewed","Cancer Medicine","""For the aims of this investigation, the following data sources were used: microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system® database; cancer registry; diabetes registry; and municipal registries.""","2021-11","Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Serraino, D","Retrospective","Cohort","Yes","not specified","Italy","Friuli Venezia Giulia (FVG) region (northeastern Italy)","","2020-02-26","2020-12-31","263042","- Odds of positive COVID PCR result in cancer vs non-cancer patients; - Risk of admission to ICU for COVID-positive cancer vs non-cancer patients (all-cause); - Risk of death for COVID-positive cancer vs non-cancer patients (all-cause)","","ICU admission; Mortality","no","Breast Cancer, Prostate Cancer, Colon Cancer, Skin Melanoma, Kidney Cancer, Lung and Larynx Cancer, Thyroid Cancer, Bladder Cancer, Endometrium Cancer, Non-Hodgkin Lymphomas, Leukaemia, Multiple Myeloma, Hodgkin Myeloma; diagnosed in last 3 months; active treatment not stated ","Controls recruited from the same data sources as cancer patients (microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system® database; cancer registry; diabetes registry; and municipal registries).","No Matching ",NA,"","","","","1452 (46.9)","3098","","","","","17876(46.7)","38268","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","650","21.0","3132","8.18","OR","2.98","2.71-3.27","","1405","45.4","7205","18.8","OR","3.58","3.32-3.86","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","425","13.7","1986","5.19","OR","2.90","2.60-3.25","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","""The hospital discharge database (updated on 31 December 2021) was used to assess admissions to ICUs"" - no further information given re defining ICU admission","37 days; all cause ","","multivariate","Age; Sex",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","673","mHR","0.92","0.72-1.17","NR","0.104 (70/673)","0.0500 (1914/38268)","mHR","0.98","0.48-2.00","NR","0.0119 (8/673)","0.013 (502/3826)","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"407","mHR","1.34","1.10-1.65","NR","0.241 (98/407)","0.0500 (1914/38268)","mHR","1.40","0.86-2.27","NR","0.0418 (17/407)","0.013 (502/3826)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"460","mHR","1.04","0.85-1.27","NR","0.235 (108/460)","0.0500 (1914/38268)","mHR","1.15","0.77-1.71","NR","0.0587 (27/460)","0.013 (502/3826)","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"2818","mHR","1.19","1.07-1.31","NR","0.172 (486/2818)","0.0500 (1914/38268)","mHR","1.04","0.82-1.32","NR","0.0291 (82/2818)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","280","mHR","1.79","1.36-2.34","NR","0.193 (54/280)","0.0500 (1914/38268)","mHR","1.50","0.83-2.73","NR","0.0393 (11/280)","0.013 (502/3826)","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"466","mHR","1.93","1.61-2.33","NR","0.255 (119/466)","0.0500 (1914/38268)","mHR","0.90","0.52-1.56","NR","0.0280 (13/466)","0.013 (502/3826)","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"68513","Udovica 2022","High mortality in patients with active malignancy and severe COVID-19: Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic","Consensus","Peer-reviewed","Magazine of European medical oncology ","","2022-05","High mortality in patients with active malignancy and severe COVID-19","Udovica S ","Retrospective","Cohort","Yes","inpatient","Austria ","Vienna ","245 consecutive patients admitted for severe COVID-19 at four different COVID-19 units in four different oncologic departments in Austria. Non-cancer control from  Department of Medicine I at the Clinic Ottakring in Vienna ","2020/03/01","2021/03/31","245","covid-19 specific in hospital mortality ","","Mortality","no","Pa- tients with active malignancy were defined through one of the following criteria: (1) diagnosis of any histologically proven malignant disease within the last 6 months (excluding basalioma), (2) receiving treatment for a malignant condition within the last 6 months, (3) metastatic or recurrent malignant disease.","Same country but different hospital   This was a 12-month retrospective analysis of 245 consecutive patients admitted for severe COVID-19 at four different COVID-19 units in four different oncologic departments in Austria. The noncancer control group consisted of patients admitted at the Department of Medicine I at the Clinic Ottakring in Vienna for severe COVID-19 but had no history of cancer within the last 5 years","Matched; ratio cancer to noncancer 89:156; age, gender, comorbidity",NA,"median ","74","range ","51-95","50.6","89","median ","76","range ","26-97","54.6","156","Other: participants were not tested for strain but paper includes: "" Of note, our study was performed between March 2020 and March 2021. In that period the SARS-CoV-2 back- ground strain and the SARS-CoV-2 alpha variant were the most commonly observed variants and vaccines were not available.""",NA,"","","","","",NA,"","","","","","","",NA,"","","14","15.7","45","28.8","cOR","0.46","0.24-0.9","","47","52.8","71","45.5","cOR","1.34","0.79-2.26","","","","","","",NA,"",NA,"10","11.2","10","6.4","cOR","1.85","0.74-4.63","","10","11.2","16","10.3","cOR","1.11","0.48-2.56","","22","24.7","24","15.4","cOR","1.81","0.94-3.46","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"17; 27; 8","19.1; 19.1; 9.0","49; 37; 35","31.4; 23.7; 22.6","cOR","0.52; 0.76; 0.34","0.28-0.97; 0.40-1.45; 0.15-0.77","","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia",NA,"others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","I calculated crude OR and CI but have left p-values blank for James to calculate as discussed with him ","","","Covid-19 specific in-hospital mortality defined as death during a COVID-19 infection requiring at least supplemental oxygen ≥6 l/min; or with signs of pulmonary manifestations of COVID-19 on chest X-ray; or death in an ICU due to respiratory or multiorgan failure. ","","univariate; multivariate; Other: Crude","Age; Comorbidities; Other: ECOG performance status",NA,"10","","","","","","","","","","","","","","","","","","","","","","","","","","","9","","","","","","","","","","","","","","","","","","","","","","","","","","","15","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"8","","","","","","","","","","","","","","","","","","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"54","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","35","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"89","uOR; mOR ","2.56; 4.59","1.47-4.47; 2.26-9.30","< 0.001; < 0.001","41/89; 41/89","43/156; 43/156","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"45","50.1","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","5","5.6","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"13","14.6","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","5.6","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","4","4.5","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","9","10.1","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"245","100","","","","","","","","","","","","","","","","","","","","","","","","","","","Of note, our study was performed between March 2020 and March 2021. In that period the SARS-CoV-2 back- ground strain and the SARS-CoV-2 alpha variant were the most commonly observed variants and vaccines were not available","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","245","100%","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"68083","Kim 2022","Characterizing cancer and COVID-19 outcomes using electronic health records","Consensus","Peer-reviewed","PLOS One","Optum® de-identified COVID-19 Electronic Health Record (EHR) Optum1’s longitudinal EHR repository is derived from more than 700 hospitals and 7000 clinics in the United States","2022-05","Characterizing cancer and COVID-19 outcomes using electronic health records","Kim, YK ","Prospective","Cohort ","Yes","not specified","USA","N/A","N/A","2020-06-01","2020-12-31","271,639","Our primary objective was to determine the effect of cancer on the outcomes of COVID-19, specifically hospitalization, intensive care unit (ICU) admission, ventilator use, and all-cause deaths occurring within 30 days of COVID-19 infection, by comparing these outcomes between COVID-19 patients with and without a cancer diagnosis. ","The secondary objective was to identify factors associated with mortality in COVID-19 patients with recent cancer treatment. Potential predictors included chemotherapy and radiation therapy within 3 months before the COVID-19, age, sex (not included for breast, endometrial, and prostate cancers), race/ethnicity, insurance type, regions, and comorbidity conditions such as chronic conditions identified and known risk factors ","Severity; Hospitalisation; ICU admission; Mortality","no","All types of cancer; Cancer diagnosed within one year before COVID diagnosis; Active treatment not stated.","Yes 253,179 pts Non cancer: 18,460 cancer with 10,246 patients with a diagnosis of cancer within 1 year","Matched; No matching ratio; Not reported.",NA,"median","66","IQR","57-76","47.3","10426","median","46","IQR","32-60","42.7","253179","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","3648","35.0","42542","16.8","",NA,"","","5183","49.7","49725","19.6","",NA,"","","1986","19.0","15599","6.2","",NA,"",NA,"2338","22.4","18270","7.2","",NA,"","","2675","25.7","18145","7.2","",NA,"","","4402","42.2","62429","24.7","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Peripheral Vascular Disease: 2574","Peripheral Vascular Disease: 24.7","Peripheral Vascular Disease: 14708","Peripheral Vascular Disease: 5.8","","","","","","","","",NA,"","","","Ventilator use","Admitted to ICU is given as an outcome","30-day mortality; all-cause","Ventilator use","univariate; multivariate","Age; Sex; Comorbidities",NA,"887","mRR","1.85","1.58–2.17","<0.001","NR","0.019 (4854/253179)","mRR","1.35","1.12–1.63","0.002","NR","0.025 (6449/253179)","mRR","1.21","0.89–1.63","0.22","NR","0.011 (2855/253179)","","mRR","1.31","1.19-1.44","<0.001","NR","0.099 (25092/253179)","","2143","mRR","1.08","0.88–1.32","0.47","NR","0.019 (4854/253179)","mRR","0.92","0.74–1.13","0.409  ","NR","0.025 (6449/253179)","mRR","1.06","0.78–1.45","0.70","NR","0.011 (2855/253179)","","mRR","0.99   ","0.90–1.09","0.876 ","NR","0.099 (25092/253179)","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"794","mRR","0.91","0.69–1.19","0.50  ","NR","0.019 (4854/253179)","mRR","0.81","0.61–1.07","0.14","NR","0.025 (6449/253179)","mRR","0.90","0.61–1.35","0.62","NR","0.011 (2855/253179)","","mRR","1.05  ","0.93–1.20","0.42","NR","0.099 (25092/253179)","","207 (liver); 121 (pancreas)","mRR (liver); mRR (pancreas)","2.46 (liver); 1.94 (pancreas)","1.80–3.36 (liver); 1.19–3.16 (pancreas)","<0.001 (liver); 0.008 (pancreas)","NR (liver); NR (pancreas)","0.019 (4854/253179) (liver); 0.019 (4854/253179) (pancreas)","mRR (liver); mRR (pancreas)","0.96 (liver);0.72 (pancreas)","0.62–1.49 (liver); 0.35–1.46 (pancreas)","0.85 (liver); 0.363 (pancreas) ","NR (liver); NR (pancreas)","0.025 (6449/253179) (liver); 0.025 (6449 /253179) (pancreas)","mRR (liver); mRR (pancreas)","1.14 (liver); 0.84 (pancreas)","0.63–2.05 (liver); 0.33–2.12 (pancreas)","0.67 (liver); 0.71 (pancreas)","NR (liver); NR (pancreas)","0.011 (2855/253179) (liver); 0.011 (2855/253179) (pancreas)","","mRR (liver); mRR (pancreas)","1.23 (liver); 0.98 (pancreas)","1.00–1.51 (liver); 0.71–1.35 (pancreas)","0.05 (liver); 0.91  (pancreas)","NR (liver); NR (pancreas)","0.099 (25092/253179) (liver); 0.099 (25092/253179) (pancreas)",NA,"474","mRR","1.15","0.86–1.53","0.34","NR","0.019 (4854/253179)","mRR","0.8","0.57–1.13","0.202","NR","0.025 (6449/253179)","mRR","0.79","0.49–1.30","0.36","NR","0.011 (2855/253179)","","mRR","1.06","0.91–1.22","0.46","NR","0.099 (25092/253179)",NA,"1781 ","mRR","0.82","0.70–0.96","0.015","NR","0.019 (4854/253179)","mRR","0.81","0.68–0.96","0.017","NR","0.025 (6449/253179)","mRR","0.78","0.60–1.01","0.055","NR","0.011 (2855/253179)","","mRR","0.95","0.88–1.02 ","0.177","NR","0.099 (25092/253179)","","291","mRR","1.62","0.96–2.74","0.07","NR","0.019 (4854/253179)","mRR","1.58","1.03–2.41","0.04","NR","0.025 (6449/253179)","mRR","1.53","0.81–2.90","0.19","NR","0.011 (2855/253179)",NA,"mRR","1.15  ","0.90–1.46","0.27","NR","0.099 (25092/253179)",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"476","mRR","0.83","0.46–1.51","0.55  ","NR","0.019 (4854/253179)","mRR","0.58","0.30–1.11","0.10  ","NR","0.025 (6449/253179)","mRR","0.38","0.12–1.19","0.1","NR","0.011 (2855/253179)","","mRR","0.76   ","0.59–0.9","0.035","NR","0.099 (25092/253179)",NA,"409","mRR","0.96","0.67–1.38","0.82","NR","0.019 (4854/253179)","mRR","0.89","0.57–1.38","0.61","NR","0.025 (6449/253179)","mRR","0.58","0.27–1.27","0.177","NR","0.011 (2855/253179)",NA,"mRR","0.86  ","0.69–1.06","0.163","NR","0.099 (25092/253179)","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"8952","mRR","1.12  ","1.04–1.22","0.004","NR","0.019 (4854/253179)","mRR","0.97","0.89–1.06","0.52","NR","0.025 (6449/253179)","mRR","0.95","0.84–1.08","0.453","NR","0.011 (2855/253179)","","mRR","1.05","1.00–1.09","0.03","NR","0.099 (25092/253179)","","2224","mRR","1.48 "," 1.30–1.68","<0.001 ","NR","0.019 (4854/253179)","mRR","1.27","1.10–1.46","0.001","NR","0.025 (6449/253179)","mRR","1.41","1.16–1.72","0.001","NR","0.011 (2855/253179)","","mRR","1.31 ","1.22–1.40"," <0.001 ","NR","0.099 (25092/253179)","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"10426","mRR","1.17","1.08-1.25","<0.001","0.075 (781/10426)","0.019 (4854/253179)","mRR","1.02","0.95-1.11","0.54","0.065 (674/10426)","0.025 (6449/253179)","mRR","1.05","0.93-1.17","0.45","0.032 (332/10426)","0.011 (2855/253179)","","mRR","1.10","1.06-1.14","<0.001","0.24 (2476/10426)","0.099 (25092/253179)","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"1580","mRR","2.09","1.82–2.39","<0.001","NR","0.019 (4854/253179)","mRR","1.33","1.13–1.56","0.001","NR","0.025 (6449/253179)","mRR","1.32","1.04-1.68","0.021","NR","0.011 (2855/253179)","","mRR","1.26   ","1.16–1.37","<0.001 ","0.24 (2476/10426)","0.099 (25092/253179)","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"NR","NR","uRR; mRR","1.31; 1.37 ","1.08-1.60; 1.12–1.69 ","0.006; 0.003","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","NR","NR","uRR; mRR","1.89; 1.83  ","1.44-2.49; 1.37–2.46","<0.001; <0.001","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"67898","Plais 2022","Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study","Consensus","Peer-reviewed","Frontiers in Oncology ","","2022-03"," Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study","Plais H","Prospective","Cohort","Yes","inpatient","France","17 French ICUs","17 French ICUs","2020-03-12","2021-03-08","409","Mortality at day 60 after ICU admission ","","Mortality","no","All types cancer; Treatment (including chemotherapy, targeted therapy, immunotherapy, radiotherapy, or surgery) administered within 6 months, or active surveillance within 6 months of ICU admission, or haematological cancer that is not in complete remission; Active treatment not stated. ","Adult patients admitted to participating ICUs without active canceras per above definition. Same cohort/hospitals/country. ","Matched; 1:3; age, antimicrobial treatment, BMI, chronic respiratory disease, congestive heart failure, hospitalisation within the last 3 months, diabetes, HIV, immunosuppressive therapy, PaO2 at baseline, SAPS II and SOFA scores, sex, organ transplant",NA,"Mean","69","NR","65-73","68.6","105","Mean","67","NR","59-75","69.4","315","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","24","22.9","107","34","",NA,"","","10","9.5","29","9.2","",NA,"","","","","","","",NA,"",NA,"1","1","8","2.5","",NA,"","","12","11.4","32","10.2","",NA,"","","8","7.6","12","3.8","","","","","26","24.8","17","5.4","","","","",NA,NA,NA,NA,"",NA,"",NA,"3 (HIV); 1 (solid organ transplantation)","2.9 (HIV); 1 (solid organ transplantation)","6 (HIV); 11 (solid organ transplantation)","1.9 (HIV); 3.5 (solid organ transplantation)","","","","","","","","",NA,"","","","","","60-day mortality after ICU admission; All-cause","","univariate; multivariate","Age; Other: Cancer type, norepinephrine use, antimicrobial treatment, treatment with hydroxychloroquine and azithromycin, age at admission, period of admittance based on definition 1st and 2nd waves of SARS-Cov-2 in France",NA,"12","","","","","","","","","","","","","","","","","","","","","","","","","","","6","","","","","","","","","","","","","","","","","","","","","","","","","","","8","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","Includes hepatobiliary cancers","","","","","",NA,NA,"10","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Grouped with upper GI ","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"2","","","","","","","","","","","","","","","","","","","","","","","","","","","2","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"54","uOR; mOR","1.88; 2.344","0.82-4.27; 0.87-6.31","0.13; 0.0262","NR; NR","0.274 (86/315); 0.274 (86/315)","","","","","","","",NA,"",NA,"","","","","","","","","","","51","uOR; mOR","3.19; 4.144","1.38-7.37; 1.24-13.83","0.0065; 0.0262","NR; NR","0.274 (86/315); 0.274 (86/315)","","","","","","","","","","","","","","","","","","","","","Endocrine: 2 ","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"105","uOR","2.3","1.24-4.28","0.0082","0.562 (59/105)","0.274 (86/315)","","","","","","","","","","","","","","","","","","","","",NA,"31","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"23","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"420","100","uOR","2.3","1.24-4.28","0.0082","0.562 (59/105)","0.274 (86/315)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","yes"
"67144","Alpert 2021","Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study","Consensus","Peer-reviewed","JNCI Cancer Spectrum","We used anonymous data from the Mount Sinai Health System (MSHS) COVID-19 registry, which includes all patients with an encounter at a MSHS facility who were diagnosed with, under investigation, or screened for COVID-19","2020-11","Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study","Alpert N","Retrospective","Cohort ","Yes","inpatient and outpatient (no breakdown)","USA ","New York ","Mount Sinai Hospital ","2020/03/01 ","2020/05/27","5556","sepsis, venous thromboembolism, acute kidney injury, intensive care unit admission, all-cause mortality.","","Severity; ICU admission; Mortality","no","All Types Cancer; newly diagnosed cancer or on active treatment   ","matched for gender, age, comorbidity ","Matched; ratio cancer:non cancer 421:5135; age, gender, comorbidity ",NA,"Mean","69.2","SE","0.7","59.4","421","Mean ","63.8","SE","0.2","56.6","5135","Not mentioned",NA,"","","","","",NA,"","","223","53","1677","32.7","cOR","2.32","1.9-2.84","","139","33","1138","22.2","cOR","1.73","1.4-2.14","","177","42","1300","25.3","cOR","2.14","1.75-2.62","","","","","","",NA,"",NA,"26","6.2","107","2.1","cOR","3.09","1.99-4.81","","70","16.6","566","11","cOR","1.61","1.23-2.11","","64","15.2","427","8.3","cOR","1.98","1.49-2.63","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"43","10.2","388","7.6","cOR","1.39","1.00-1.94","","Chronic lung disease = COPD + Asthma  CVD = HF + AF + coronary artery disease   Others = Obesity","Others = Obesity","Others = Obesity","Others = Obesity",NA,"Others = Obesity","Others = Obesity ","Chronic lung disease = COPD + Asthma  CVD = HF + AF + coronary artery disease   Others = Obesity  I calculated crude OR and CI and have left p-values for James as discussed ","sepsis defined as more than 1 of the following; temperature greater than 100.4 degrees F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","ICU defined as intensive care unit, no other info given ","all cause","sepsis defined as more than 1 of the following; temperature greater than 100.4 degrees F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","multivariate; Other: Crude","Age; Sex; Comorbidities",NA,"19","","","","","","","","","","","","","","","","","","","","","","","","","","","46","","","","","","","","","","","","","","","","","","","","","","","","","","","5","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"32","","","","","","","","","","","","","","","","","","","","","","","","","","","32","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"13","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"81","","","","","","","","","","","","","","","","","","","","","","","","","","","20","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"15","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"273","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","96","","","","","","","","","","","","","","","","","","","","","","","","","","","26","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","26","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"421","mOR","1.02 ","0.81-1.29","0.86","129/421","1272/5135","mOR","1.04","0.80-1.34","1.0","82/421","913/5135","mOR ","1.31","1.06-1.61","0.05","253/421","2821/5135","the paper did not specify severity, but specified sepsis which I have included in the severity column   unspecified = multiple sites ","","","","","","","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","421","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"5556","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","5556","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"67122","Rugge 2022","Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy","Consensus","Peer-reviewed","Tumori Journal","Regional Population-Based Cancer Registries","2021-12","Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy","Rugge M","Retrospective","cohort","Yes","Other: Inpatient and outpatient (with breakdown)","Italy","Veneto and Friuli Venezia Giulia","","2020-02-22","2020-07-31","21101","Patients’ hospitalization (whatever the clinical setting, other than the intensive care unit [ICU]) and admission to an ICU","Vital status (mortality)","Hospitalisation; ICU admission; Mortality","no","All Types Cancer; Diagnosed ≤12 months before testing positive for COVID-19; Active treatment not stated","The resident population of the Veneto and Friuli Venezia Giulia regions (in North-Eastern Italy) who tested positive for SARS-CoV-2 without a history of cancer","No matching; No matching ratio",NA,"Median","73","IQR","62-82.25","53.4","324","Median","51","IQR","36-66","40.1","20777","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","No definition stated","","multivariate; Other: Crude","Age; Sex; Comorbidities",NA,"23 (lung)","uOR","7.19","3.15-16.42","3.987E-06","0.435 (10/23)","0.097 (2008/20777)","uOR","1.24","0.17-9.22","0.845","0.001 (1/23)","0.035 (734/20777)","","","","","","","","uOR","9.18","3.31-25.50","2.663E-05","0.737 (14/19)","0.234 (4685/20047)","Lung","34","uOR","1.61","0.62-4.17","0.333","0.147 (5/34)","0.097 (2008/20777)","","","","","0.000 (0/34)","0.035 (734/20777)","","","","","","","","uOR","1.82","0.84-3.95","0.131","0.357 (10/28)","0.234 (4685/20047)","Breast","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"34 (colorectal)","uOR","5.10","2.52-10.32","7.996E-06","0.353 (12/34)","0.097 (2008/20777)","uOR","4.71","1.82-12.20","0.0015","0.147 (5/34)","0.035 (734/20777)","","","","","","","","uOR","3.53","1.66-7.52","0.0011","0.519 (14/27)","0.234 (4685/20047)","Colorectal","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"63 (prostate, urology)","uOR","3.74","2.16-6.47","3.482E-06","0.286 (18/63)","0.097 (2008/20777)","uOR","1.85","0.67-5.11","0.240","0.063 (4/63)","0.035 (734/20777)","","","","","","","","uOR","3.17","1.90-5.29","1.293E-05","0.492 (29/59)","0.234 (4685/20047)","Urinary Bladder+Prostate","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","41","uOR","8.07","4.36-14.94","9.317E-11","0.463 (19/41)","0.097 (2008/20777)","uOR","1.40","0.34-5.81","0.659","0.049 (2/41)","0.035 (734/20777)","","","","","","","","uOR","8.53","4.11-17.69","1.790E-08","0.722 (26/36)","0.234 (4685/20047)","","129","uOR","4.35","3.00-6.33","7.188E-14","0.318 (41/129)","0.097 (2008/20777)","uOR","1.33","0.59-3.03","0.508","0.047 (6/129)","0.035 (734/20777)","",NA,"",NA,NA,NA,"","uOR","3.92","2.65-5.81","3.303E-11","0.545 (55/101)","0.234 (4685/20047)","Others",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"324","uOR;mOR","4.48;3.013","3.535-5.681;2.290-3.949","<0.001; NR","0.324 (105/324); 0.324 (105/324)","0.097 (2008/20777); 0.097 (2008/20777)","uOR;mOR","1.61;1.049","0.993-2.599;0.621-1.664","0.053; NR","0.056 (18/324); 0.056 (18/324)","0.035 (734/20777); 0.035 (734/20777)","","","","","","","","uOR;mOR","4.22;2.883","3.30-5.40;2.215-3.762","<0.001; NR","0.562 (198/263); 0.562 (198/263)","0.234 (4685/20047); 0.234 (4685/20047)","",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","yes"
"66861","Chavez-MacGregor 2022","Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients with or Without Cancer","Consensus","Peer-reviewed","JAMA Oncology","Optum de-identified COVID-19 electronic health record data set, which contains data from more than 700 hospitals and 7000 clinics across the US.","2022-01","Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer","Chavez-MacGregor M","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","USA","N/A","N/A - but included >700 hospitals in the US","2020-01-01","2021-01-28","507307","30-day Mortality, 30-day Mechanical ventilation, 30-day ICU stay, 30-day Hospitalisation","30-day Mechanical ventilation, 30-day ICU stay, 30-day Hospitalisation","Severity; Hospitalisation; ICU admission; Mortality","no","Used the following ICD criteria from electronic health records:  ICD-9: 140-165, 170-176, 179-209, 239  ICD-10: C00-C26, C30-C41, C43, C45-C58, C60-C80, C7A, C7B, C81-C96, D37-D47.   Cancer group was split into: (a) patients receiving treatment (radiotherapy or systemic therapy) <3 months before COVID diagnosis, and (b) patients not receiving recent treatment.  Both groups are included in our review given that all cancer patients had to have at least two ICD codes for cancer within 1 year before COVID diagnosis.","Controls drawn from the same data source (Optum COVID-19 electronic health record data set) - so from the same >700 hospitals and the same >7000 clinics across the US.","Matched; 1:5; age, sex, comorbidities",NA,"Median","With recent cancer treatment: 66; Without recent cancer treatment: 68","IQR","With recent cancer treatment: 57-75; Without recent cancer treatment: 59-77","47.9","14287","Median","48","IQR","32-61","44.5","493020","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"1547 (Severe obesity (BMI ≥40))","10.8 (Severe obesity (BMI ≥40))","50115 (Severe obesity (BMI ≥40))","10.2 (Severe obesity (BMI ≥40))","uOR (Severe obesity (BMI ≥40))","1.07 (Severe obesity (BMI ≥40))","1.02-1.13 (Severe obesity (BMI ≥40))","","","","","",NA,"","","","no definition stated","ICU admission within 30-days of positive COVID test. Identified from the following electronic health record codes: 0200 - General classification ICU, 0201 - Surgical ICU, 0202 - Medical ICU, 0203 - Pediatric ICU, 0204 - Psychiatric ICU, 0206 - Intermediate ICU, 0207 - Burn care, 0208 - Trauma care, 0209 - Other intensive care, 0210 - General classification cardiac care unit (CCU), 0211 - Myocardial infarction care, 0212 - Pulmonary care, 0213 - Heart transplant, 0214 - Intermediate CCU, 0219 - Other coronary care.","30 day mortality; covid-19 specific mortality","30-day Mechanical ventilation","multivariate","Age; Sex; Comorbidities; Other: race, diagnosis period, skilled nurse facility, insurance, geographical region",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"14287","aOR (No recent treatment);aOR (recent treatment)","0.93 (No recent treatment);1.74 (Recent treatment)","0.84-1.02 (No recent treatment);1.54-1.96 (Recent treatment)","0.12 (No recent treatment);<0.001 (Recent treatment)","0.049 (No recent treatment);0.087 (Recent treatment)","0.016 (7888/493020);0.016 (7888/493020)","aOR (No recent treatment);aOR (recent treatment)","0.98 (No recent treatment);1.69 (Recent treatment)","0.91-1.06 (No recent treatment);1.54-1.87 (Recent treatment)","0.61 (No recent treatment);<0.001 (Recent treatment)","0.075 (749/9991) (No recent treatment);0.137 (589/4296) (Recent treatment)","0.033 (16270/493020);0.033 (16270/493020)","aOR (No recent treatment);aOR (recent treatment)","0.61 (No recent treatment);1.00 (recent treatment)","0.54-0.68 (No recent treatment);0.88-1.13 (recent treatment)","<0.001 (No recent treatment);0.94 (recent treatment)","0.038 (380/9991) (No recent treatment); 0.073 (314/4296) (recent treatment)","0.022 (10846/493020);0.022 (10846/493020)","No recent treatment;Recent treatment","aOR (No recent treatment);aOR (recent treatment)","0.79;1.19","0.75-0.83;1.11-1.27","<0.001;<0.001","0.251 (2508/9991);0.357 (1534/4296)","0.146 (71981/493020);0.016 (7888/493020)","No recent treatment;recent treatment",NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"Chemotherapy: 1634; Chemo-immunotherapy: 195","Chemotherapy: 11.4;  Chemo-immunotherapy: 1.4","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","Targeted therapy or endocrine therapy: 1068","Targeted therapy or endocrine therapy: 7.5","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"Targeted therapy or endocrine therapy: 1068","Targeted therapy or endocrine therapy: 7.5","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","592","4.1","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","806","5.6","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"65844","Bertuzzi 2021","Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy","Consensus","Peer-reviewed","British Journal of Cancer","Medical records at IRCCS, Rozzano, Italy","2021-05","Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy","Bertuzzi AF","Retrospective","cohort","Yes","inpatient","Italy","Lombardy","IRCCS, Rozzano","2020-02-27","2020-05-20","557","Mortality","ICU Admission","ICU admission; Mortality","no","All Types Cancer; presence of localised or metastatic disease at covid onset; no active treatment","controls from the same hospital","Matched; 1:4; age, comorbidities",NA,"Mean","71","95%CI","67-74","67.4","46","Mean","65","95%CI","64-66","67.3","511","Not mentioned",NA,"9","19.6","41","8.0","uOR","0.28","0.12-0.65","0.002131","21","45.7","263","51.6","uOR","0.79","0.43-1.45","0.442006","12","26.1","125","24.5","uOR","1.09","0.55-2.16","0.812080","","","","","",NA,"","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"12 (dyslipidemia); 13 (Coronary Artery Disease)","26.7 (dyslipidemia); 28.9 (Coronary Artery Disease)","42 (dyslipidemia); 44 (Coronary Artery Disease)","23.3 (dyslipidemia); 24.4 (Coronary Artery Disease)","uOR;uOR","1.45  (dyslipidemia); 1.79 (Coronary Artery Disease)","0.74-2.85; 0.92-3.49","0.279626; 0.081512","","","","",NA,"","","","no definition stated","no definition stated","in-hospital fatality rate; covid-19 specific mortality","no definition stated","univariate; multivariate","Age",NA,"9","","","","","","","","","","","","","","","","","","","","","","","","","","","3","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"33","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","","","","","","","","","","","","","","","6 (all GU); 10 (all GI)","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"46","uHR; mHR","2.79; 2.26","1.76-4.42; 1.39-3.657","<0.001; <0.001","0.500 (23/46); 0.500 (23/46)","0.202 (103/511); 0.202 (103/511)","","","","","","","","","","","","","","","","","","","","",NA,"17","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"29","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"13","28.3","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","4","8.7","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"1","2.2","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","10.9","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","4","8.7","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","21","45.7","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"557","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"62182","Sng 2020","Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience","Consensus","Peer-reviewed","Frontiers in Oncology","Electronic health records of the University College London Hospitals NHS Foundation Trust.","2020-11","Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience","Sng C. C. T.","Retrospective","Cohort","Yes","inpatient","UK","London","University College London Hospitals NHS Foundation Trust","2020-03-01","2020-05-31","320","All-cause mortality.","","Mortality","no","All types solid cancer;  active cancer = cancer diagnosis or anti-cancer treatment within the last 12 months or radiological or biochemical evidence of active or recurrent cancer.","Patients with no evidence of cancer in their EHR recruited from the same hospital.","Matched; 94:226; age, sex. ",NA,"median","71","iqr","62-80","66","94","median","70.5","iqr","60-80","67","226","Not mentioned",NA,"7","7","13","6","uOR","1.32","0.51-3.42","0.568403","37","39","123","54","uOR","0.54","0.33-0.89","0.014103","24","26","73","32","uOR","0.72","0.42-1.23","0.230143","18","19","59","26","uOR","0.67","0.37-1.21","0.184800","12","13","37","16","uOR","0.75","0.37-1.51","0.414594","3","3","4","2","uOR","1.83","0.40-8.34","0.428448","12","13","26","12","uOR","1.13","0.54 - 2.34","0.750680","14","15","47","21","uOR","0.67","0.35-1.28","0.220784","4","4","13","6","uOR","0.73","0.23-2.29","0.586580",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","immunosuppressed = ongoing corticosteroid use; comorbidities compare control cohort to 98 patients with a history of cancer (of whom 58 had active cancer)","","","",NA,"","","","","","3 month mortality; all-cause.","","multivariate","Age; Comorbidities; Other: Ethnicity.",NA,"15","aHR","0.70","0.28-1.79","0.46","0.333 (5/15)","","","","","","","","","","","","","","","","","","","","","","8","aHR","1.56","0.55-4.38","0.40","0.500 (4/8)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"24","aHR","1.65","0.85-3.19","0.14","0.542 (13/24)","","","","","","","","","","","","","","","","","","","","","","9","aHR","0.60","0.19-1.96","0.40","0.333 (3/9)","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"58","aHR","1.64","1.03-2.6","0.04","0.448 (26/58)","","","","","","","","","","","","","","","","","","","","","total = active cancer only, subtypes include active and non-active",NA,"58","","","","","0.448 (26/58)","0.341 (77/226)","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"19","uHR","1.13","0.54-2.37","0.75","0.474 (9/19)","0.341 (77/226)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"15","25.9","mHR","2.04","0.84-4.9","0.11","0.467 (7/15)","0.341 (77/226)","","","","","","","","","",NA,"","","","","","","","","","","8","13.8","mHR","1.94","0.74-5.1","0.18","0.625 (5/8)","0.341 (77/226)","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"2","3.45","mHR","3.44","0.44-27.2","0.24","0.500 (1/2)","0.341 (77/226)","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","8.62","mHR","1.94","0.45-8.4","0.38","0.400 (2/5)","0.341 (77/226)","","","","","","","","","",NA,"","","","","","","","","","","4","6.90","mHR","1.70","0.39-7.3","0.48","0.500 (2/4)","0.341 (77/226)","","","","","","","","","",NA,"",NA,NA,"","","","","","","","3","5.17","mHR","1.4","0.18-10.8","0.75","0.333 (1/3)","0.341 (77/226)",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"320","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
"62120","Brar 2020","COVID-19 severity and outcomes in patients with cancer: A matched cohort study","Consensus","Peer-reviewed","Journal of Clinical Oncology","Hospital records for Weill Cornell Medicine and Lower Manhattan Hospital","2020-09","COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study","Brar G.","Retrospective","Cohort","Yes","inpatient","USA","New York City","2 New York-Presbyterian hospitals: Weill Cornell Medicine and Lower Manhattan Hospital","2020-03-03","2020-05-15","585","Composite incident outcome of: 1) ICU admission 2) Intubation 3) Death","","Severity; ICU admission; Mortality","no","All types of cancer; definition of active not stated; active treatment not stated","Patients at the same two hospitals with no cancer diagnostic code","Matched; 1:4; age, gender, comorbidities ",NA,"Median","72.5","IQR","64.2-79.9","54.7%","117","Median","71.2","IQR","62.1-79.6","54.7%","468","Not mentioned",NA,"39","33.4","129","27.7","uOR","1.31","0.22-0.85","0.22","62","53.0","269","57.5","uOR","0.83","0.21-0.56","0.38","38","32.5","136","29.1","uOR","1.17","0.22-0.76","0.47","","","","","",NA,"","","","","","","",NA,"",NA,"3","","2","0.4","uOR","6.13","0.92-1.01","0.02","3","2.6","23","4.9","uOR","0.51","0.15-0.62","0.27","","","","","","","","","0","0","3","0.6","uOR","n/a","n/a","n/a",NA,NA,NA,NA,"",NA,"",NA,"22; 13; 9; 6","18.8; 11.1; 7.7; 5.1","78; 32; 33;29","16.7; 6.8; 7.1; 6.2","uOR; uOR; uOR; uOR","1.16; 1.70; 1.10; 0.82","0.27-0.69; 0.35-0.86; 0.39-0.51; 0.33-0.46","0.58; 0.12; 0.81; 0.66","CAD; HF; COPD; Asthma","","","",NA,"","","","No definition stated","","No definition stated","Intensive care unit, intubation, or death","multivariate","Age; Sex; Comorbidities",NA,"1","","","","","","","","","","","","","","","","","","","","","","","","","","","15","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"22","","","","","","","","","","","","","","","","","","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"75","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","42","","","","","","","","","","","","","","","","","","","","","","","","","","","19","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","Combined lower + upper GI",NA,"",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"117","uHR; mHR","0.74; 0.98","0.53-1.03; 0.58-1.67",">.05; 0.894","29/117; 0.248","100/468; 0.214","","","","","","","mHR","0.80","0.57-1.13",">.05","","","","","","","","","","",NA,"22","","","","","","","","","","","",NA,NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"26","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","27","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"52","44.4","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","32","27.4","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","14","12.0","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","21","18.0","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"","","","","",NA,NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"585","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,"","","","","","","","","",NA,NA,NA,NA,NA,"","",NA,"","","","","","","","","","","",NA,"","","","","",NA,NA,NA,"","","",NA,NA,NA,"","","","",NA,"","","","",NA,NA,NA,NA,"","","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","no"
